Introduzione
Questa pagina fornisce un'analisi completa dello storico delle operazioni di insider trading note di Randal J Kirk. Gli insider sono funzionari, direttori o investitori importanti di una società. In generale, è illegale per gli insider effettuare operazioni di compravendita nelle loro aziende sulla base di informazioni materiali non pubbliche. Ciò non significa che sia illegale per loro effettuare qualsiasi operazioni di trading nelle proprie aziende. Tuttavia, devono segnalare tutte le operazioni alla SEC tramite un modulo 4. Nonostante queste restrizioni, la ricerca accademica suggerisce che gli insider, in generale, tendono a sovraperformare il mercato nelle proprie società.
Redditività media delle transazioni
La redditività media delle transazioni è il rendimento medio di tutti gli acquisti effettuati sul mercato aperto dagli insider negli ultimi tre anni. Pe calcolarla, esaminiamo tutti gli acquisti non pianificati effettuati dall'insider sul mercato aperto, escludendo tutte le operazioni che sono state parte di un piano di trading 10b5-1. Calcoliamo quindi la performance media di queste operazioni nell'arco di 3, 6 e 12 mesi e facciamo la media di ciascuna di queste durate per generare un indicatore di performance finale per ogni operazione. Infine, facciamo la media di tutti gli indicatori di performance per calcolare un indicatore di performance per l'insider. Questo elenco comprende solo gli insider che hanno effettuato almeno tre operazioni negli ultimi due anni.
Se la redditività delle operazioni di questo insider è "N/D", l'insider non ha effettuato acquisti sul mercato aperto negli ultimi tre anni, oppure le operazioni effettuate sono troppo recenti per poter calcolare un indicatore di performance affidabile.
Frequenza di aggiornamento: giornaliera
Società con posizioni di insider dichiarate
I depositi SEC indicano che Randal J Kirk ha dichiarato partecipazioni o transazioni nelle seguenti società:
Titolo | Ruolo | Ultime partecipazioni dichiarate |
---|---|---|
US:PGEN / Precigen, Inc. | Director, 10% Owner | 64.779.510 |
US:AQB / AquaBounty Technologies, Inc. | 10% Owner | 3.747 |
US:FCSC / Fibrocell Science Inc. | 10% Owner | 0 |
US:SYN / Synthetic Biologics Inc | 10% Owner | 165.332 |
US:HSGX / Histogenics Corporation | 10% Owner | 1.692.366 |
US:ZIOP / Alaunos Therapeutics Inc | Director | 0 |
US:PRPO / Precipio, Inc. | 10% Owner | 27.151 |
US:HALO / Halozyme Therapeutics, Inc. | 10% Owner | 1.897.610 |
US:SNGX / Soligenix, Inc. | 10% Owner | 85.397 |
US:APHB / Ampliphi Biosciences Corp. | 10% Owner | 674.169 |
US:OGEN / Oragenics, Inc. | 10% Owner | 14.481.089 |
Come interpretare i grafici
I grafici seguenti mostrano l'andamento dei titoli dopo ogni operazione di mercato aperto non pianificata effettuata da Randal J Kirk. Per operazioni non pianificate si intendono operazioni non effettuate nell'ambito di un piano di trading 10b5-1. La performance dei titoli è rappresentata come variazione percentuale cumulativa del prezzo delle azioni. Ad esempio, se un'operazione di insider è stata effettuata il 1° gennaio 2019, il grafico mostrerà la variazione percentuale giornaliera del titolo fino ad oggi. Se il prezzo dell'azione passasse da 10 a 15 dollari durante questo periodo, la variazione percentuale cumulativa del prezzo dell'azione sarebbe del 50%. Una variazione di prezzo da 10 a 20 dollari sarebbe del 100%, mentre una variazione di prezzo da 10 a 5 dollari sarebbe del -50%.
In definitiva, cerchiamo di determinare la correlazione tra le operazioni dell'insider e i rendimenti in eccesso (positivi o negativi) del prezzo dell'azione, al fine di capire se l'insider sta programmando le proprie operazioni per trarre profitto da informazioni privilegiate. Immaginiamo che un insider stia facendo questo. In questa situazione, ci aspetteremmo (a) rendimenti positivi dopo gli acquisti, oppure (b) rendimenti negativi dopo le vendite. Nel caso (a), il grafico ACQUISTO mostrerebbe una serie di curve ascendenti, indicando rendimenti positivi dopo ogni operazione di acquisto. Nel caso (b), il grafico VENDITA mostrerebbe una serie di curve inclinate verso il basso, indicando rendimenti negativi dopo ogni operazione di vendita.
Tuttavia, questo non è sufficiente per trarre conclusioni. Se, ad esempio, il prezzo delle azioni della società è aumentato in maniera non ciclica per molti anni, allora ci aspetteremmo che tutti i grafici post-acquisto abbiano una pendenza rivolta verso l'alto. Allo stesso modo, ribassi non ciclici per molti anni darebbero luogo a grafici post-negoziazione rivolti verso il basso. Nessuno di questi grafici suggerisce un'attività di insider trading.
L'indicatore più forte sarebbe una situazione in cui il prezzo delle azioni fosse estremamente ciclico e vi fossero segnali positivi nel grafico ACQUISTO e curve negative nel grafico VENDITA. Questa situazione suggerirebbe che l'insider sta programmando le operazioni di trading per trarne un vantaggio finanziario.
Acquisti di insider AQB / AquaBounty Technologies, Inc. - Analisi degli utili a breve termine
In questa sezione analizziamo la redditività di ogni acquisto non pianificato di insider sul mercato aperto effettuato in AQB / AquaBounty Technologies, Inc.. Questa analisi aiuta a capire se l'insider genera costantemente rendimenti anomali e se vale la pena seguirlo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.
La tabella seguente mostra gli acquisti più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.
Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.
Vendite di insider AQB / AquaBounty Technologies, Inc. - Analisi delle perdite a breve termine
In questa sezione, analizziamo l'evitamento delle perdite a breve termine di ogni vendita di insider non pianificata ed effettuata sul mercato aperto in AQB / AquaBounty Technologies, Inc.. Un modello coerente di evitamento delle perdite può suggerire che future transazioni di vendita potrebbero predire cali di prezzo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.
La tabella seguente mostra le vendite più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.
Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.
Acquisti di insider ARMP / Armata Pharmaceuticals, Inc. - Analisi degli utili a breve termine
In questa sezione analizziamo la redditività di ogni acquisto non pianificato di insider sul mercato aperto effettuato in AQB / AquaBounty Technologies, Inc.. Questa analisi aiuta a capire se l'insider genera costantemente rendimenti anomali e se vale la pena seguirlo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.
La tabella seguente mostra gli acquisti più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.
Data dell'operazione | Ticker | Insider | Azioni dichiarate |
Prezzo dichiarato |
Azioni rettificate |
Prezzo rettificato |
Base di costo | Giorni fino al massimo |
Prezzo al massimo |
Profitto massimo ($) |
Rendimento massimo (%) |
---|---|---|---|---|---|---|---|---|---|---|---|
2015-03-16 | APHB | KIRK RANDAL J | 13.939.392 | 0,1650 | 13.939.392 | 0,1650 | 2.300.000 | 144 |
Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.
Vendite di insider ARMP / Armata Pharmaceuticals, Inc. - Analisi delle perdite a breve termine
In questa sezione, analizziamo l'evitamento delle perdite a breve termine di ogni vendita di insider non pianificata ed effettuata sul mercato aperto in AQB / AquaBounty Technologies, Inc.. Un modello coerente di evitamento delle perdite può suggerire che future transazioni di vendita potrebbero predire cali di prezzo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.
La tabella seguente mostra le vendite più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.
Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.
Acquisti di insider HALO / Halozyme Therapeutics, Inc. - Analisi degli utili a breve termine
In questa sezione analizziamo la redditività di ogni acquisto non pianificato di insider sul mercato aperto effettuato in AQB / AquaBounty Technologies, Inc.. Questa analisi aiuta a capire se l'insider genera costantemente rendimenti anomali e se vale la pena seguirlo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.
La tabella seguente mostra gli acquisti più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.
Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.
Vendite di insider HALO / Halozyme Therapeutics, Inc. - Analisi delle perdite a breve termine
In questa sezione, analizziamo l'evitamento delle perdite a breve termine di ogni vendita di insider non pianificata ed effettuata sul mercato aperto in AQB / AquaBounty Technologies, Inc.. Un modello coerente di evitamento delle perdite può suggerire che future transazioni di vendita potrebbero predire cali di prezzo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.
La tabella seguente mostra le vendite più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.
Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.
Acquisti di insider OCGN / Ocugen, Inc. - Analisi degli utili a breve termine
In questa sezione analizziamo la redditività di ogni acquisto non pianificato di insider sul mercato aperto effettuato in AQB / AquaBounty Technologies, Inc.. Questa analisi aiuta a capire se l'insider genera costantemente rendimenti anomali e se vale la pena seguirlo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.
La tabella seguente mostra gli acquisti più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.
Data dell'operazione | Ticker | Insider | Azioni dichiarate |
Prezzo dichiarato |
Azioni rettificate |
Prezzo rettificato |
Base di costo | Giorni fino al massimo |
Prezzo al massimo |
Profitto massimo ($) |
Rendimento massimo (%) |
---|---|---|---|---|---|---|---|
Non sono note operazioni di mercato aperto non pianificate per questa combinazione di insider e titoli. |
Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.
Vendite di insider OCGN / Ocugen, Inc. - Analisi delle perdite a breve termine
In questa sezione, analizziamo l'evitamento delle perdite a breve termine di ogni vendita di insider non pianificata ed effettuata sul mercato aperto in AQB / AquaBounty Technologies, Inc.. Un modello coerente di evitamento delle perdite può suggerire che future transazioni di vendita potrebbero predire cali di prezzo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.
La tabella seguente mostra le vendite più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.
Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.
Acquisti di insider OGEN / Oragenics, Inc. - Analisi degli utili a breve termine
In questa sezione analizziamo la redditività di ogni acquisto non pianificato di insider sul mercato aperto effettuato in AQB / AquaBounty Technologies, Inc.. Questa analisi aiuta a capire se l'insider genera costantemente rendimenti anomali e se vale la pena seguirlo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.
La tabella seguente mostra gli acquisti più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.
Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.
Vendite di insider OGEN / Oragenics, Inc. - Analisi delle perdite a breve termine
In questa sezione, analizziamo l'evitamento delle perdite a breve termine di ogni vendita di insider non pianificata ed effettuata sul mercato aperto in AQB / AquaBounty Technologies, Inc.. Un modello coerente di evitamento delle perdite può suggerire che future transazioni di vendita potrebbero predire cali di prezzo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.
La tabella seguente mostra le vendite più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.
Data dell'operazione | Ticker | Insider | Azioni dichiarate |
Prezzo dichiarato |
Azioni rettificate |
Prezzo rettificato |
Base di costo | Giorni fino al minimo |
Prezzo al minimo |
Perdita massima evitata ($) |
Perdita massima evitata (%) |
---|---|---|---|---|---|---|---|
Non sono note operazioni di mercato aperto non pianificate per questa combinazione di insider e titoli. |
Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.
Acquisti di insider PGEN / Precigen, Inc. - Analisi degli utili a breve termine
In questa sezione analizziamo la redditività di ogni acquisto non pianificato di insider sul mercato aperto effettuato in AQB / AquaBounty Technologies, Inc.. Questa analisi aiuta a capire se l'insider genera costantemente rendimenti anomali e se vale la pena seguirlo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.
La tabella seguente mostra gli acquisti più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.
Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.
Vendite di insider PGEN / Precigen, Inc. - Analisi delle perdite a breve termine
In questa sezione, analizziamo l'evitamento delle perdite a breve termine di ogni vendita di insider non pianificata ed effettuata sul mercato aperto in AQB / AquaBounty Technologies, Inc.. Un modello coerente di evitamento delle perdite può suggerire che future transazioni di vendita potrebbero predire cali di prezzo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.
La tabella seguente mostra le vendite più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.
Data dell'operazione | Ticker | Insider | Azioni dichiarate |
Prezzo dichiarato |
Azioni rettificate |
Prezzo rettificato |
Base di costo | Giorni fino al minimo |
Prezzo al minimo |
Perdita massima evitata ($) |
Perdita massima evitata (%) |
---|---|---|---|---|---|---|---|
Non sono note operazioni di mercato aperto non pianificate per questa combinazione di insider e titoli. |
Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.
Acquisti di insider PRPO / Precipio, Inc. - Analisi degli utili a breve termine
In questa sezione analizziamo la redditività di ogni acquisto non pianificato di insider sul mercato aperto effettuato in AQB / AquaBounty Technologies, Inc.. Questa analisi aiuta a capire se l'insider genera costantemente rendimenti anomali e se vale la pena seguirlo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.
La tabella seguente mostra gli acquisti più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.
Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.
Vendite di insider PRPO / Precipio, Inc. - Analisi delle perdite a breve termine
In questa sezione, analizziamo l'evitamento delle perdite a breve termine di ogni vendita di insider non pianificata ed effettuata sul mercato aperto in AQB / AquaBounty Technologies, Inc.. Un modello coerente di evitamento delle perdite può suggerire che future transazioni di vendita potrebbero predire cali di prezzo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.
La tabella seguente mostra le vendite più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.
Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.
Acquisti di insider SNGX / Soligenix, Inc. - Analisi degli utili a breve termine
In questa sezione analizziamo la redditività di ogni acquisto non pianificato di insider sul mercato aperto effettuato in AQB / AquaBounty Technologies, Inc.. Questa analisi aiuta a capire se l'insider genera costantemente rendimenti anomali e se vale la pena seguirlo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.
La tabella seguente mostra gli acquisti più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.
Data dell'operazione | Ticker | Insider | Azioni dichiarate |
Prezzo dichiarato |
Azioni rettificate |
Prezzo rettificato |
Base di costo | Giorni fino al massimo |
Prezzo al massimo |
Profitto massimo ($) |
Rendimento massimo (%) |
---|---|---|---|---|---|---|---|
Non sono note operazioni di mercato aperto non pianificate per questa combinazione di insider e titoli. |
Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.
Vendite di insider SNGX / Soligenix, Inc. - Analisi delle perdite a breve termine
In questa sezione, analizziamo l'evitamento delle perdite a breve termine di ogni vendita di insider non pianificata ed effettuata sul mercato aperto in AQB / AquaBounty Technologies, Inc.. Un modello coerente di evitamento delle perdite può suggerire che future transazioni di vendita potrebbero predire cali di prezzo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.
La tabella seguente mostra le vendite più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.
Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.
Acquisti di insider TCRT / Alaunos Therapeutics, Inc. - Analisi degli utili a breve termine
In questa sezione analizziamo la redditività di ogni acquisto non pianificato di insider sul mercato aperto effettuato in AQB / AquaBounty Technologies, Inc.. Questa analisi aiuta a capire se l'insider genera costantemente rendimenti anomali e se vale la pena seguirlo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.
La tabella seguente mostra gli acquisti più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.
Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.
Vendite di insider TCRT / Alaunos Therapeutics, Inc. - Analisi delle perdite a breve termine
In questa sezione, analizziamo l'evitamento delle perdite a breve termine di ogni vendita di insider non pianificata ed effettuata sul mercato aperto in AQB / AquaBounty Technologies, Inc.. Un modello coerente di evitamento delle perdite può suggerire che future transazioni di vendita potrebbero predire cali di prezzo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.
La tabella seguente mostra le vendite più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.
Data dell'operazione | Ticker | Insider | Azioni dichiarate |
Prezzo dichiarato |
Azioni rettificate |
Prezzo rettificato |
Base di costo | Giorni fino al minimo |
Prezzo al minimo |
Perdita massima evitata ($) |
Perdita massima evitata (%) |
---|---|---|---|---|---|---|---|
Non sono note operazioni di mercato aperto non pianificate per questa combinazione di insider e titoli. |
Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.
Acquisti di insider TOVX / Theriva Biologics, Inc. - Analisi degli utili a breve termine
In questa sezione analizziamo la redditività di ogni acquisto non pianificato di insider sul mercato aperto effettuato in AQB / AquaBounty Technologies, Inc.. Questa analisi aiuta a capire se l'insider genera costantemente rendimenti anomali e se vale la pena seguirlo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.
La tabella seguente mostra gli acquisti più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.
Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.
Vendite di insider TOVX / Theriva Biologics, Inc. - Analisi delle perdite a breve termine
In questa sezione, analizziamo l'evitamento delle perdite a breve termine di ogni vendita di insider non pianificata ed effettuata sul mercato aperto in AQB / AquaBounty Technologies, Inc.. Un modello coerente di evitamento delle perdite può suggerire che future transazioni di vendita potrebbero predire cali di prezzo. L'analisi riguarda l'anno successivo a ciascuna operazione, e i risultati sono teorici.
La tabella seguente mostra le vendite più recenti sul mercato aperto che non facevano parte di un piano di trading automatico.
Il prezzo rettificato è il prezzo rettificato per il frazionamento azionario. Leazioni rettificate sono le azioni rettificate per il frazionamento azionario.
Storico delle operazioni degli insider
Questa tabella mostra l'elenco completo delle operazioni effettuate da Randal J Kirk come comunicato alla Securities Exchange Commission (SEC).
Data di deposito | Data della transazione | Modulo | Ticker | Titolo | Codice | Azioni | Azioni rimanenti | Variazione percentuale |
Prezzo dell'azione |
Valore della transazione |
Valore rimanente |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-17 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
M - Exercise | 174.825 | 64.779.510 | 0,27 | ||||
2025-03-17 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
A - Award | 57.471 | 64.604.685 | 0,09 | 1,74 | 100.000 | 112.412.152 | |
2024-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 23.529.411 | 64.547.214 | 57,36 | 0,85 | 19.999.999 | 54.865.132 | |
2024-05-03 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 6.085.471 | 6.085.471 | |||||
2024-05-03 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 8.896.412 | 41.017.803 | 27,70 | ||||
2024-05-03 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | -691.929 | 0 | -100,00 | ||||
2024-05-03 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | -1.383.858 | 0 | -100,00 | ||||
2024-05-03 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | -832.500 | 0 | -100,00 | ||||
2024-05-03 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | -2.497.500 | 0 | -100,00 | ||||
2024-05-03 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | -4.995.000 | 0 | -100,00 | ||||
2024-05-03 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | -19.711 | 0 | -100,00 | ||||
2024-05-03 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | -59.133 | 0 | -100,00 | ||||
2024-05-03 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | -118.266 | 0 | -100,00 | ||||
2024-05-03 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | -8.790.674 | 0 | -100,00 | ||||
2024-05-03 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | -58.800 | 0 | -100,00 | ||||
2024-03-18 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
A - Award | 69.930 | 32.121.391 | 0,22 | 1,43 | 100.000 | 45.933.589 | |
2024-03-12 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
M - Exercise | 213.675 | 32.051.461 | 0,67 | ||||
2023-12-29 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 96.686 | 1.096.686 | 9,67 | 1,41 | 136.327 | 1.546.327 | |
2023-08-17 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 119.411 | 31.837.786 | 0,38 | 1,51 | 180.311 | 48.075.057 | |
2023-08-17 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 200.000 | 31.718.375 | 0,63 | 1,52 | 304.000 | 48.211.930 | |
2023-08-17 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 80.589 | 31.518.375 | 0,26 | 1,53 | 123.301 | 48.223.114 | |
2023-08-17 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 100.000 | 31.437.786 | 0,32 | 1,50 | 150.000 | 47.156.679 | |
2023-03-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
A - Award | 85.470 | 31.337.786 | 0,27 | 1,17 | 100.000 | 36.665.210 | |
2023-02-24 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
M - Exercise | 123.152 | 31.252.316 | 0,40 | ||||
2023-01-31 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 11.428.571 | 31.129.164 | 58,01 | 1,75 | 19.999.999 | 54.476.037 | |
2023-01-06 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
M - Exercise | 3.443 | 19.700.593 | 0,02 | ||||
2022-10-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 26.361 | 1.015.604 | 2,66 | ||||
2022-10-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 6.326 | 453.731 | 1,41 | ||||
2022-10-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 8.435 | 351.120 | 2,46 | ||||
2022-10-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 10.544 | 578.079 | 1,86 | ||||
2022-10-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 10.544 | 578.079 | 1,86 | ||||
2022-10-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 42.177 | 1.637.040 | 2,64 | ||||
2022-10-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 42.177 | 1.637.040 | 2,64 | ||||
2022-10-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 105.445 | 3.944.437 | 2,75 | ||||
2022-10-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 105.445 | 3.944.437 | 2,75 | ||||
2022-10-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 10.544 | 489.438 | 2,20 | ||||
2022-10-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 660.091 | 19.697.150 | 3,47 | ||||
2022-10-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 26.374 | 1.015.626 | 2,67 | ||||
2022-03-28 |
|
4 | PGEN |
PRECIGEN, INC.
Restricted Stock Units |
M - Exercise | -32.425 | 0 | -100,00 | ||||
2022-03-28 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
M - Exercise | 32.425 | 19.037.059 | 0,17 | ||||
2022-02-24 |
|
4 | PGEN |
PRECIGEN, INC.
Restricted Stock Units |
A - Award | 123.152 | 123.152 | |||||
2022-02-24 |
|
4 | PGEN |
PRECIGEN, INC.
Option to Purchase Common Stock (Right to Buy) |
A - Award | 166.378 | 166.378 | |||||
2022-02-24 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
A - Award | 49.261 | 19.004.634 | 0,26 | 2,03 | 100.000 | 38.579.407 | |
2022-01-05 |
|
4 | PGEN |
PRECIGEN, INC.
Restricted Stock Units |
M - Exercise | 3.444 | 3.444 | |||||
2022-01-05 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
M - Exercise | 3.444 | 18.741.568 | 0,02 | ||||
2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -9.042 | 3.747 | -70,70 | 2,10 | -18.988 | 7.869 | |
2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -18.082 | 7.493 | -70,70 | 2,10 | -37.972 | 15.735 | |
2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -7.323 | 3.035 | -70,70 | 2,10 | -15.378 | 6.374 | |
2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -14.644 | 6.068 | -70,70 | 2,10 | -30.752 | 12.743 | |
2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -33.347 | 13.562 | -71,09 | 2,10 | -70.029 | 28.480 | |
2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -8.810 | 3.651 | -70,70 | 2,10 | -18.501 | 7.667 | |
2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -26.430 | 10.953 | -70,70 | 2,10 | -55.503 | 23.001 | |
2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -52.859 | 21.906 | -70,70 | 2,10 | -111.004 | 46.003 | |
2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -209 | 86 | -70,85 | 2,10 | -439 | 181 | |
2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -626 | 259 | -70,73 | 2,10 | -1.315 | 544 | |
2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -1.251 | 519 | -70,68 | 2,10 | -2.627 | 1.090 | |
2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -3.294 | 1.365 | -70,70 | 2,10 | -6.917 | 2.866 | |
2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -14 | 6 | -70,00 | 2,10 | -29 | 13 | |
2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -67.291 | 27.886 | -70,70 | 2,10 | -141.311 | 58.561 | |
2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -4.269.495 | 1.769.343 | -70,70 | 2,10 | -8.965.940 | 3.715.620 | |
2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -53.028 | 21.976 | -70,70 | 2,10 | -111.359 | 46.150 | |
2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -444.702 | 184.291 | -70,70 | 2,10 | -933.874 | 387.011 | |
2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -249.384 | 103.349 | -70,70 | 2,10 | -523.706 | 217.033 | |
2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -2.262 | 937 | -70,71 | 2,10 | -4.750 | 1.968 | |
2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -54.462 | 22.570 | -70,70 | 2,10 | -114.370 | 47.397 | |
2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -1.002.663 | 340.514 | -74,65 | 2,10 | -2.105.592 | 715.079 | |
2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -980.473 | 331.318 | -74,74 | 2,10 | -2.058.993 | 695.768 | |
2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -280.018 | 116.044 | -70,70 | 2,10 | -588.038 | 243.692 | |
2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -279.121 | 115.672 | -70,70 | 2,10 | -586.154 | 242.911 | |
2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -278.618 | 115.463 | -70,70 | 2,10 | -585.098 | 242.472 | |
2021-11-24 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
S - Sale | -4.742.552 | 1.965.386 | -70,70 | 2,10 | -9.959.359 | 4.127.311 | |
2021-11-23 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 486.335 | 1.000.000 | 94,68 | 3,58 | 1.741.079 | 3.580.000 | |
2021-11-23 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 200 | 513.665 | 0,04 | 3,52 | 704 | 1.808.101 | |
2021-11-23 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 43.900 | 513.465 | 9,35 | 3,60 | 158.040 | 1.848.474 | |
2021-11-23 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 161.904 | 469.565 | 52,62 | 3,59 | 581.235 | 1.685.738 | |
2021-11-23 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 307.661 | 307.661 | 3,75 | 1.153.729 | 1.153.729 | ||
2021-09-24 |
|
4 | PGEN |
PRECIGEN, INC.
Restricted Stock Units |
M - Exercise | 53.571 | 53.571 | |||||
2021-09-24 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
M - Exercise | 53.571 | 18.738.124 | 0,29 | ||||
2021-06-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 14.168 | 989.252 | 1,45 | ||||
2021-06-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 14.159 | 989.243 | 1,45 | ||||
2021-06-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 4.531 | 342.685 | 1,34 | ||||
2021-06-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 5.663 | 567.535 | 1,01 | ||||
2021-06-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 5.663 | 567.535 | 1,01 | ||||
2021-06-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 22.655 | 1.594.863 | 1,44 | ||||
2021-06-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 22.655 | 1.594.863 | 1,44 | ||||
2021-06-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 56.638 | 3.838.992 | 1,50 | ||||
2021-06-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 56.638 | 3.838.992 | 1,50 | ||||
2021-06-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 3.398 | 447.405 | 0,77 | ||||
2021-06-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 5.663 | 479.857 | 1,19 | ||||
2021-06-07 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 354.557 | 18.684.553 | 1,93 | ||||
2021-03-29 |
|
4 | PGEN |
PRECIGEN, INC.
Restricted Stock Units |
A - Award | 32.425 | 32.425 | |||||
2021-03-29 |
|
4 | PGEN |
PRECIGEN, INC.
Option to Purchase Common Stock (Right to Buy) |
A - Award | 44.214 | 44.214 | |||||
2021-03-29 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
A - Award | 12.970 | 18.329.996 | 0,07 | 7,71 | 99.999 | 141.324.269 | |
2021-03-12 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Option to Purchase Common Stock (Right to Buy) |
A - Award | 2.500 | 2.500 | |||||
2021-01-05 |
|
4 | PGEN |
PRECIGEN, INC.
Restricted Stock Units |
M - Exercise | 3.444 | 6.887 | 100,03 | ||||
2021-01-05 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
M - Exercise | 3.444 | 18.317.026 | 0,02 | ||||
2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 122 | 11.917 | 1,03 | ||||
2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 10.358 | 10.358 | |||||
2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 242 | 44.543 | 0,55 | ||||
2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 242 | 44.543 | 0,55 | ||||
2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 20.712 | 44.301 | 87,80 | ||||
2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 20.712 | 44.301 | 87,80 | ||||
2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 24 | 5.866 | 0,41 | ||||
2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 3.328 | 5.842 | 132,38 | ||||
2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 121 | 15.939 | 0,76 | ||||
2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 152 | 17.758 | 0,86 | ||||
2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 42 | 4.583 | 0,92 | ||||
2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 42 | 4.583 | 0,92 | ||||
2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 1.848 | 4.541 | 68,62 | ||||
2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 1.848 | 4.541 | 68,62 | ||||
2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 42 | 3.204 | 1,33 | ||||
2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 30 | 3.831 | 0,79 | ||||
2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 303 | 40.540 | 0,75 | ||||
2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 303 | 40.540 | 0,75 | ||||
2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 18.482 | 40.237 | 84,96 | ||||
2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 18.482 | 40.237 | 84,96 | ||||
2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 1.704 | 318.199 | 0,54 | ||||
2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 70.092 | 316.495 | 28,45 | ||||
2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | -3.637 | 0 | -100,00 | ||||
2020-12-21 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | -199.682 | 0 | -100,00 | ||||
2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 8.100 | 1.260.538 | 0,65 | ||||
2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 8.100 | 1.260.538 | 0,65 | ||||
2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 691.929 | 691.929 | |||||
2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 16.200 | 2.976.063 | 0,55 | ||||
2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 16.200 | 2.976.063 | 0,55 | ||||
2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 1.383.857 | 2.959.863 | 87,81 | ||||
2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 1.383.858 | 1.383.858 | |||||
2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 1.620 | 444.007 | 0,37 | ||||
2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 222.264 | 442.387 | 100,97 | ||||
2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 10.125 | 1.572.208 | 0,65 | ||||
2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 2.835 | 561.872 | 0,51 | ||||
2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 2.835 | 561.872 | 0,51 | ||||
2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 123.476 | 559.037 | 28,35 | ||||
2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 123.476 | 559.037 | 28,35 | ||||
2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 2.835 | 473.231 | 0,60 | ||||
2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 2.025 | 338.154 | 0,60 | ||||
2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 20.250 | 3.782.354 | 0,54 | ||||
2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 20.250 | 3.782.354 | 0,54 | ||||
2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 1.234.757 | 3.762.104 | 48,86 | ||||
2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 1.234.757 | 3.762.104 | 48,86 | ||||
2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 113.716 | 18.313.582 | 0,62 | ||||
2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | 4.682.816 | 18.199.866 | 34,64 | ||||
2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | -243.001 | 0 | -100,00 | ||||
2020-12-21 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
J - Other | -13.340.645 | 0 | -100,00 | ||||
2020-09-28 |
|
4 | PGEN |
PRECIGEN, INC.
Restricted Stock Units |
A - Award | 53.571 | 53.571 | |||||
2020-09-28 |
|
4 | PGEN |
PRECIGEN, INC.
Option to Purchase Common Stock (Right to Buy) |
A - Award | 74.656 | 74.656 | |||||
2020-09-28 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
A - Award | 21.428 | 13.517.050 | 0,16 | 3,50 | 74.998 | 47.309.675 | |
2020-08-13 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
P - Purchase | 4.000.000 | 9.175.000 | 77,29 | 2,50 | 10.000.000 | 22.937.500 | |
2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 1.664 | 220.123 | 0,76 | 4,26 | 7.089 | 937.724 | |
2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 1.993 | 212.653 | 0,95 | 4,26 | 8.490 | 905.902 | |
2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 10.779 | 435.561 | 2,54 | 4,26 | 45.919 | 1.855.490 | |
2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 8.952 | 1.562.083 | 0,58 | 4,26 | 38.136 | 6.654.474 | |
2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 30.514 | 2.527.347 | 1,22 | 4,26 | 129.990 | 10.766.498 | |
2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 10.792 | 470.396 | 2,35 | 4,26 | 45.974 | 2.003.887 | |
2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 16.824 | 1.581.431 | 1,08 | 4,26 | 71.670 | 6.736.896 | |
2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 29.652 | 2.286.308 | 1,31 | 4,26 | 126.318 | 9.739.672 | |
2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 10.775 | 471.359 | 2,34 | 4,26 | 45.902 | 2.007.989 | |
2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 278.921 | 13.495.622 | 2,11 | 4,26 | 1.188.203 | 57.491.350 | |
2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 3.355 | 218.459 | 1,56 | 4,50 | 15.098 | 983.066 | |
2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 4.018 | 210.660 | 1,94 | 4,50 | 18.081 | 947.970 | |
2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 21.741 | 424.782 | 5,39 | 4,50 | 97.834 | 1.911.519 | |
2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 18.054 | 1.553.131 | 1,18 | 4,50 | 81.243 | 6.989.090 | |
2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 61.544 | 2.496.833 | 2,53 | 4,50 | 276.948 | 11.235.748 | |
2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 21.765 | 459.604 | 4,97 | 4,50 | 97.942 | 2.068.218 | |
2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 33.934 | 1.564.607 | 2,22 | 4,50 | 152.703 | 7.040.732 | |
2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 59.806 | 2.256.656 | 2,72 | 4,50 | 269.127 | 10.154.952 | |
2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 21.733 | 460.584 | 4,95 | 4,50 | 97.798 | 2.072.628 | |
2020-08-13 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 562.568 | 13.216.701 | 4,45 | 4,50 | 2.531.556 | 59.475.154 | |
2020-05-18 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Option to Purchase Common Stock |
A - Award | 2.000 | 2.000 | |||||
2020-04-02 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
A - Award | 76.628 | 10.588.601 | 0,73 | 2,61 | 199.999 | 27.636.249 | |
2020-03-20 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 420.336 | 10.511.973 | 4,17 | 2,72 | 1.143.314 | 28.592.567 | |
2020-03-20 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 79.664 | 10.091.637 | 0,80 | 2,05 | 163.311 | 20.687.856 | |
2020-03-20 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 500.000 | 10.011.973 | 5,26 | 1,87 | 935.000 | 18.722.390 | |
2020-03-03 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
A - Award | 45.571 | 22.730.215 | 0,20 | 4,39 | 200.057 | 99.785.644 | |
2020-02-18 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
P - Purchase | 5.175.000 | 5.175.000 | 1,50 | 7.762.500 | 7.762.500 | ||
2020-02-04 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 24.787 | 182.200 | 15,75 | 5,86 | 145.252 | 1.067.692 | |
2020-02-04 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 29.684 | 151.802 | 24,31 | 5,86 | 173.948 | 889.560 | |
2020-02-04 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 160.606 | 337.234 | 90,93 | 5,86 | 941.151 | 1.976.191 | |
2020-02-04 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 133.370 | 1.299.267 | 11,44 | 5,86 | 781.548 | 7.613.705 | |
2020-02-04 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 454.642 | 1.832.054 | 33,01 | 5,86 | 2.664.202 | 10.735.836 | |
2020-02-04 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 160.785 | 366.548 | 78,14 | 5,86 | 942.200 | 2.147.971 | |
2020-02-04 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 250.674 | 1.316.798 | 23,51 | 5,86 | 1.468.950 | 7.716.436 | |
2020-02-04 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 441.800 | 1.675.873 | 35,80 | 5,86 | 2.588.948 | 9.820.616 | |
2020-02-04 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 160.546 | 367.560 | 77,55 | 5,86 | 940.800 | 2.153.902 | |
2020-02-04 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
P - Purchase | 4.155.802 | 22.684.644 | 22,43 | 5,86 | 24.353.000 | 132.932.014 | |
2020-02-04 |
|
4 | PGEN |
PRECIGEN, INC.
Common Stock |
A - Award | 33.223 | 18.528.842 | 0,18 | 6,02 | 200.002 | 111.543.629 | |
2020-01-07 |
|
4 | XON |
INTREXON CORP
Restricted Stock Units |
M - Exercise | 3.443 | 10.332 | 49,98 | ||||
2020-01-07 |
|
4 | XON |
INTREXON CORP
Common Stock |
M - Exercise | 3.443 | 18.495.619 | 0,02 | ||||
2020-01-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 141.445 | 3.188.586 | 4,64 | 5,66 | 800.579 | 18.047.397 | |
2020-01-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 34.434 | 18.492.176 | 0,19 | 5,81 | 200.062 | 107.439.543 | |
2019-12-17 |
|
4 | FCSC |
Fibrocell Science, Inc.
Series A Convertible Preferred Stock |
C - Conversion | -1.161 | 0 | -100,00 | ||||
2019-12-17 |
|
4 | FCSC |
Fibrocell Science, Inc.
Series A Convertible Preferred Stock |
C - Conversion | -1.746 | 0 | -100,00 | ||||
2019-12-17 |
|
4 | FCSC |
Fibrocell Science, Inc.
Series A Convertible Preferred Stock |
C - Conversion | -3 | 0 | -100,00 | ||||
2019-12-17 |
|
4 | FCSC |
Fibrocell Science, Inc.
Series A Convertible Preferred Stock |
C - Conversion | -106 | 0 | -100,00 | ||||
2019-12-17 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
U - Other | -539.337 | 0 | -100,00 | 3,00 | -1.618.011 | ||
2019-12-17 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
C - Conversion | 112.617 | 539.337 | 26,39 | ||||
2019-12-17 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
U - Other | -1.324.328 | 0 | -100,00 | 3,00 | -3.972.984 | ||
2019-12-17 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
C - Conversion | 169.602 | 1.324.328 | 14,69 | ||||
2019-12-17 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
U - Other | -2.453 | 0 | -100,00 | 3,00 | -7.359 | ||
2019-12-17 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
C - Conversion | 291 | 2.453 | 13,46 | ||||
2019-12-17 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
U - Other | -80.160 | 0 | -100,00 | 3,00 | -240.480 | ||
2019-12-17 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
C - Conversion | 10.282 | 80.160 | 14,71 | ||||
2019-12-03 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 149.543 | 3.047.141 | 5,16 | 5,35 | 800.055 | 16.302.204 | |
2019-12-03 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 35.536 | 18.457.742 | 0,19 | 5,63 | 200.068 | 103.917.087 | |
2019-11-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 134.628 | 2.897.598 | 4,87 | 5,94 | 799.690 | 17.211.732 | |
2019-11-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 36.069 | 18.422.206 | 0,20 | 5,54 | 199.822 | 102.059.021 | |
2019-10-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 130.761 | 2.762.970 | 4,97 | 6,12 | 800.257 | 16.909.376 | |
2019-10-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 33.373 | 18.386.137 | 0,18 | 5,99 | 199.904 | 110.132.961 | |
2019-09-03 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 107.265 | 2.632.209 | 4,25 | 7,46 | 800.197 | 19.636.279 | |
2019-09-03 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 30.088 | 18.352.764 | 0,16 | 6,65 | 200.085 | 122.045.881 | |
2019-08-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 102.477 | 2.524.944 | 4,23 | 7,81 | 800.345 | 19.719.813 | |
2019-08-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 25.758 | 18.322.676 | 0,14 | 7,76 | 199.882 | 142.183.966 | |
2019-07-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 146.487 | 2.422.517 | 6,44 | 5,46 | 799.819 | 13.226.943 | |
2019-07-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 28.467 | 18.296.918 | 0,16 | 7,03 | 200.123 | 128.627.334 | |
2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 29.647 | 1.142.758 | 2,66 | 5,26 | 155.943 | 6.010.907 | |
2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 59.295 | 975.084 | 6,47 | 5,26 | 311.892 | 5.128.942 | |
2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 59.295 | 975.084 | 6,47 | 5,26 | 311.892 | 5.128.942 | |
2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 34.788 | 1.113.111 | 3,23 | 5,23 | 181.941 | 5.821.571 | |
2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 69.577 | 915.789 | 8,22 | 5,23 | 363.888 | 4.789.576 | |
2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 69.577 | 915.789 | 8,22 | 5,23 | 363.888 | 4.789.576 | |
2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1.201 | 157.413 | 0,77 | 5,26 | 6.317 | 827.992 | |
2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2.483 | 122.118 | 2,08 | 5,26 | 13.061 | 642.341 | |
2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 3.328 | 176.628 | 1,92 | 5,26 | 17.505 | 929.063 | |
2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 12.089 | 1.165.897 | 1,05 | 5,26 | 63.588 | 6.132.618 | |
2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 27.846 | 1.377.412 | 2,06 | 5,26 | 146.470 | 7.245.187 | |
2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 3.387 | 205.763 | 1,67 | 5,26 | 17.816 | 1.082.313 | |
2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 11.911 | 1.066.124 | 1,13 | 5,26 | 62.652 | 5.607.812 | |
2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 26.779 | 1.234.073 | 2,22 | 5,26 | 140.858 | 6.491.224 | |
2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 3.528 | 207.014 | 1,73 | 5,26 | 18.557 | 1.088.894 | |
2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 129.803 | 18.268.451 | 0,72 | 5,26 | 682.764 | 96.092.052 | |
2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1.409 | 156.212 | 0,91 | 5,23 | 7.369 | 816.989 | |
2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2.914 | 119.635 | 2,50 | 5,23 | 15.240 | 625.691 | |
2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 3.905 | 173.300 | 2,31 | 5,23 | 20.423 | 906.359 | |
2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 14.185 | 1.153.808 | 1,24 | 5,23 | 74.188 | 6.034.416 | |
2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 32.675 | 1.349.566 | 2,48 | 5,23 | 170.890 | 7.058.230 | |
2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 3.975 | 202.376 | 2,00 | 5,23 | 20.789 | 1.058.426 | |
2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 13.976 | 1.054.213 | 1,34 | 5,23 | 73.094 | 5.513.534 | |
2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 31.423 | 1.207.294 | 2,67 | 5,23 | 164.342 | 6.314.148 | |
2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 4.140 | 203.486 | 2,08 | 5,23 | 21.652 | 1.064.232 | |
2019-06-10 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 152.311 | 18.138.648 | 0,85 | 5,23 | 796.587 | 94.865.129 | |
2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 9.024 | 1.078.323 | 0,84 | 5,17 | 46.654 | 5.574.930 | |
2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 18.048 | 846.212 | 2,18 | 5,17 | 93.308 | 4.374.916 | |
2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 18.048 | 846.212 | 2,18 | 5,17 | 93.308 | 4.374.916 | |
2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 18.086 | 1.069.299 | 1,72 | 4,78 | 86.451 | 5.111.249 | |
2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 36.171 | 828.164 | 4,57 | 4,78 | 172.897 | 3.958.624 | |
2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 36.171 | 828.164 | 4,57 | 4,78 | 172.897 | 3.958.624 | |
2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 365 | 154.803 | 0,24 | 5,17 | 1.887 | 800.332 | |
2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 755 | 116.721 | 0,65 | 5,17 | 3.903 | 603.448 | |
2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1.014 | 169.395 | 0,60 | 5,17 | 5.242 | 875.772 | |
2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 3.679 | 1.139.623 | 0,32 | 5,17 | 19.020 | 5.891.851 | |
2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 8.476 | 1.316.891 | 0,65 | 5,17 | 43.821 | 6.808.326 | |
2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1.032 | 198.401 | 0,52 | 5,17 | 5.335 | 1.025.733 | |
2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 3.624 | 1.040.237 | 0,35 | 5,17 | 18.736 | 5.378.025 | |
2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 8.152 | 1.175.871 | 0,70 | 5,17 | 42.146 | 6.079.253 | |
2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1.074 | 199.346 | 0,54 | 5,17 | 5.553 | 1.030.619 | |
2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 39.508 | 17.986.337 | 0,22 | 5,17 | 204.256 | 92.989.362 | |
2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 184.889 | 2.276.030 | 8,84 | 4,33 | 800.569 | 9.855.210 | |
2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 732 | 154.438 | 0,48 | 4,78 | 3.499 | 738.214 | |
2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1.515 | 115.966 | 1,32 | 4,78 | 7.242 | 554.317 | |
2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2.030 | 168.381 | 1,22 | 4,78 | 9.703 | 804.861 | |
2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 7.374 | 1.135.944 | 0,65 | 4,78 | 35.248 | 5.429.812 | |
2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 16.987 | 1.308.415 | 1,32 | 4,78 | 81.198 | 6.254.224 | |
2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2.066 | 197.369 | 1,06 | 4,78 | 9.875 | 943.424 | |
2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 7.266 | 1.036.613 | 0,71 | 4,78 | 34.731 | 4.955.010 | |
2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 16.336 | 1.167.719 | 1,42 | 4,78 | 78.086 | 5.581.697 | |
2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2.152 | 198.272 | 1,10 | 4,78 | 10.287 | 947.740 | |
2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 44.283 | 17.946.829 | 0,25 | 4,52 | 200.159 | 81.119.667 | |
2019-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 79.184 | 17.902.546 | 0,44 | 4,78 | 378.500 | 85.574.170 | |
2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1.661 | 153.706 | 1,09 | 4,79 | 7.956 | 736.252 | |
2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 3.435 | 114.451 | 3,09 | 4,79 | 16.454 | 548.220 | |
2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 4.604 | 166.351 | 2,85 | 4,79 | 22.053 | 796.821 | |
2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 16.723 | 1.128.570 | 1,50 | 4,79 | 80.103 | 5.405.850 | |
2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 38.521 | 1.291.428 | 3,07 | 4,79 | 184.516 | 6.185.940 | |
2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 4.686 | 195.303 | 2,46 | 4,79 | 22.446 | 935.501 | |
2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 16.477 | 1.029.347 | 1,63 | 4,79 | 78.925 | 4.930.572 | |
2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 37.044 | 1.151.383 | 3,32 | 4,79 | 177.441 | 5.515.125 | |
2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 4.880 | 196.120 | 2,55 | 4,79 | 23.375 | 939.415 | |
2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 179.561 | 17.823.362 | 1,02 | 4,79 | 860.097 | 85.373.904 | |
2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1.013 | 152.045 | 0,67 | 4,68 | 4.741 | 711.571 | |
2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2.096 | 111.016 | 1,92 | 4,68 | 9.809 | 519.555 | |
2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2.809 | 161.747 | 1,77 | 4,68 | 13.146 | 756.976 | |
2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 10.204 | 1.111.847 | 0,93 | 4,68 | 47.755 | 5.203.444 | |
2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 23.504 | 1.252.907 | 1,91 | 4,68 | 109.999 | 5.863.605 | |
2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2.859 | 190.617 | 1,52 | 4,68 | 13.380 | 892.088 | |
2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 10.053 | 1.012.870 | 1,00 | 4,68 | 47.048 | 4.740.232 | |
2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 22.603 | 1.114.339 | 2,07 | 4,68 | 105.782 | 5.215.107 | |
2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2.978 | 191.240 | 1,58 | 4,68 | 13.937 | 895.003 | |
2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 109.560 | 17.643.801 | 0,62 | 4,68 | 512.741 | 82.572.989 | |
2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 41.012 | 1.051.213 | 4,06 | 4,79 | 196.447 | 5.035.310 | |
2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 82.024 | 791.993 | 11,55 | 4,79 | 392.895 | 3.793.646 | |
2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 82.024 | 791.993 | 11,55 | 4,79 | 392.895 | 3.793.646 | |
2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 25.024 | 1.010.201 | 2,54 | 4,68 | 117.112 | 4.727.741 | |
2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 50.048 | 709.969 | 7,58 | 4,68 | 234.225 | 3.322.655 | |
2019-05-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 50.048 | 709.969 | 7,58 | 4,68 | 234.225 | 3.322.655 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 14.486 | 985.177 | 1,49 | 4,68 | 67.794 | 4.610.628 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 28.972 | 659.921 | 4,59 | 4,68 | 135.589 | 3.088.430 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 28.972 | 659.921 | 4,59 | 4,68 | 135.589 | 3.088.430 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 17.150 | 970.691 | 1,80 | 4,67 | 80.090 | 4.533.127 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 34.300 | 630.949 | 5,75 | 4,67 | 160.181 | 2.946.532 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 34.300 | 630.949 | 5,75 | 4,67 | 160.181 | 2.946.532 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 23.037 | 953.541 | 2,48 | 4,70 | 108.274 | 4.481.643 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 46.075 | 596.649 | 8,37 | 4,70 | 216.552 | 2.804.250 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 46.075 | 596.649 | 8,37 | 4,70 | 216.552 | 2.804.250 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 587 | 151.032 | 0,39 | 4,68 | 2.747 | 706.830 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1.213 | 108.920 | 1,13 | 4,68 | 5.677 | 509.746 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1.626 | 158.938 | 1,03 | 4,68 | 7.610 | 743.830 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 5.907 | 1.101.643 | 0,54 | 4,68 | 27.645 | 5.155.689 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 13.606 | 1.229.403 | 1,12 | 4,68 | 63.676 | 5.753.606 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1.655 | 187.758 | 0,89 | 4,68 | 7.745 | 878.707 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 5.820 | 1.002.817 | 0,58 | 4,68 | 27.238 | 4.693.184 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 13.084 | 1.091.736 | 1,21 | 4,68 | 61.233 | 5.109.324 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1.724 | 188.262 | 0,92 | 4,68 | 8.068 | 881.066 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 63.423 | 17.534.241 | 0,36 | 4,68 | 296.820 | 82.060.248 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 695 | 150.445 | 0,46 | 4,67 | 3.246 | 702.578 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1.436 | 107.707 | 1,35 | 4,67 | 6.706 | 502.992 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1.925 | 157.312 | 1,24 | 4,67 | 8.990 | 734.647 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 6.993 | 1.095.736 | 0,64 | 4,67 | 32.657 | 5.117.087 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 16.108 | 1.215.797 | 1,34 | 4,67 | 75.224 | 5.677.772 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1.959 | 186.103 | 1,06 | 4,67 | 9.149 | 869.101 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 6.890 | 996.997 | 0,70 | 4,67 | 32.176 | 4.655.976 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 15.491 | 1.078.652 | 1,46 | 4,67 | 72.343 | 5.037.305 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2.041 | 186.538 | 1,11 | 4,67 | 9.531 | 871.132 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 75.088 | 17.470.818 | 0,43 | 4,67 | 350.661 | 81.588.720 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 933 | 149.750 | 0,63 | 4,70 | 4.385 | 703.825 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1.929 | 106.271 | 1,85 | 4,70 | 9.066 | 499.474 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2.586 | 155.387 | 1,69 | 4,70 | 12.154 | 730.319 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 9.393 | 1.088.743 | 0,87 | 4,70 | 44.147 | 5.117.092 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 21.638 | 1.199.689 | 1,84 | 4,70 | 101.699 | 5.638.538 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2.632 | 184.144 | 1,45 | 4,70 | 12.370 | 865.477 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 9.255 | 990.107 | 0,94 | 4,70 | 43.498 | 4.653.503 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 20.808 | 1.063.161 | 2,00 | 4,70 | 97.798 | 4.996.857 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2.741 | 184.497 | 1,51 | 4,70 | 12.883 | 867.136 | |
2019-05-24 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 100.864 | 17.395.730 | 0,58 | 4,70 | 474.061 | 81.759.931 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 12.045 | 930.504 | 1,31 | 4,74 | 57.093 | 4.410.589 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 24.089 | 550.574 | 4,58 | 4,74 | 114.182 | 2.609.721 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 24.089 | 550.574 | 4,58 | 4,74 | 114.182 | 2.609.721 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 60.334 | 918.459 | 7,03 | 4,63 | 279.346 | 4.252.465 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 120.668 | 526.485 | 29,73 | 4,63 | 558.693 | 2.437.626 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 120.668 | 526.485 | 29,73 | 4,63 | 558.693 | 2.437.626 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 12.106 | 858.125 | 1,43 | 4,69 | 56.777 | 4.024.606 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 24.212 | 405.817 | 6,34 | 4,69 | 113.554 | 1.903.282 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 24.212 | 405.817 | 6,34 | 4,69 | 113.554 | 1.903.282 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 488 | 148.817 | 0,33 | 4,74 | 2.313 | 705.393 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1.009 | 104.342 | 0,98 | 4,74 | 4.783 | 494.581 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1.352 | 152.801 | 0,89 | 4,74 | 6.408 | 724.277 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 4.911 | 1.079.350 | 0,46 | 4,74 | 23.278 | 5.116.119 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 11.313 | 1.178.051 | 0,97 | 4,74 | 53.624 | 5.583.962 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1.376 | 181.512 | 0,76 | 4,74 | 6.522 | 860.367 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 4.839 | 980.852 | 0,50 | 4,74 | 22.937 | 4.649.238 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 10.879 | 1.042.353 | 1,05 | 4,74 | 51.566 | 4.940.753 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1.433 | 181.756 | 0,79 | 4,74 | 6.792 | 861.523 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 52.735 | 17.294.866 | 0,31 | 4,74 | 249.964 | 81.977.665 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2.444 | 148.329 | 1,68 | 4,63 | 11.316 | 686.763 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 5.053 | 103.333 | 5,14 | 4,63 | 23.395 | 478.432 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 6.772 | 151.449 | 4,68 | 4,63 | 31.354 | 701.209 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 24.601 | 1.074.439 | 2,34 | 4,63 | 113.903 | 4.974.653 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 56.668 | 1.166.738 | 5,10 | 4,63 | 262.373 | 5.401.997 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 6.893 | 180.136 | 3,98 | 4,63 | 31.915 | 834.030 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 24.239 | 976.013 | 2,55 | 4,63 | 112.227 | 4.518.940 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 54.496 | 1.031.474 | 5,58 | 4,63 | 252.316 | 4.775.725 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 7.180 | 180.323 | 4,15 | 4,63 | 33.243 | 834.895 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 264.156 | 17.242.131 | 1,56 | 4,63 | 1.223.042 | 79.831.067 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 490 | 145.885 | 0,34 | 4,69 | 2.298 | 684.201 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1.014 | 98.280 | 1,04 | 4,69 | 4.756 | 460.933 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1.359 | 144.677 | 0,95 | 4,69 | 6.374 | 678.535 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 4.936 | 1.049.838 | 0,47 | 4,69 | 23.150 | 4.923.740 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 11.370 | 1.110.070 | 1,03 | 4,69 | 53.325 | 5.206.228 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1.383 | 173.243 | 0,80 | 4,69 | 6.486 | 812.510 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 4.864 | 951.774 | 0,51 | 4,69 | 22.812 | 4.463.820 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 10.935 | 976.978 | 1,13 | 4,69 | 51.285 | 4.582.027 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1.441 | 173.143 | 0,84 | 4,69 | 6.758 | 812.041 | |
2019-05-21 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 53.002 | 16.977.975 | 0,31 | 4,69 | 248.579 | 79.626.703 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 62.810 | 846.019 | 8,02 | 4,59 | 288.298 | 3.883.227 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 125.620 | 381.605 | 49,07 | 4,59 | 576.596 | 1.751.567 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 125.620 | 94.620.773 | 0,13 | 4,59 | 576.596 | 434.309.348 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 29.500 | 783.209 | 3,91 | 4,37 | 128.915 | 3.422.623 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 59.000 | 255.985 | 29,95 | 4,37 | 257.830 | 1.118.654 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 59.000 | 255.985 | 29,95 | 4,37 | 257.830 | 1.118.654 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 75.386 | 753.709 | 11,11 | 4,25 | 320.390 | 3.203.263 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 150.773 | 196.985 | 326,26 | 4,25 | 640.785 | 837.186 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 150.773 | 196.985 | 326,26 | 4,25 | 640.785 | 837.186 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2.544 | 145.395 | 1,78 | 4,59 | 11.677 | 667.363 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 5.260 | 97.266 | 5,72 | 4,59 | 24.143 | 446.451 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 7.050 | 143.318 | 5,17 | 4,59 | 32.360 | 657.830 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 25.611 | 1.044.902 | 2,51 | 4,59 | 117.554 | 4.796.100 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 58.994 | 1.098.700 | 5,67 | 4,59 | 270.782 | 5.043.033 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 7.176 | 171.860 | 4,36 | 4,59 | 32.938 | 788.837 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 25.234 | 946.910 | 2,74 | 4,59 | 115.824 | 4.346.317 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 56.733 | 966.043 | 6,24 | 4,59 | 260.404 | 4.434.137 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 7.474 | 171.702 | 4,55 | 4,59 | 34.306 | 788.112 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 275.001 | 16.924.973 | 1,65 | 4,59 | 1.262.255 | 77.685.626 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1.195 | 142.851 | 0,84 | 4,37 | 5.222 | 624.259 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2.471 | 92.006 | 2,76 | 4,37 | 10.798 | 402.066 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 3.311 | 136.268 | 2,49 | 4,37 | 14.469 | 595.491 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 12.029 | 1.019.291 | 1,19 | 4,37 | 52.567 | 4.454.302 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 27.708 | 1.039.706 | 2,74 | 4,37 | 121.084 | 4.543.515 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 3.370 | 164.684 | 2,09 | 4,37 | 14.727 | 719.669 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 11.852 | 921.676 | 1,30 | 4,37 | 51.793 | 4.027.724 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 26.646 | 909.310 | 3,02 | 4,37 | 116.443 | 3.973.685 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 3.511 | 164.228 | 2,18 | 4,37 | 15.343 | 717.676 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 129.158 | 16.649.972 | 0,78 | 4,37 | 564.420 | 72.760.378 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 3.053 | 141.656 | 2,20 | 4,25 | 12.975 | 602.038 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 6.314 | 89.535 | 7,59 | 4,25 | 26.834 | 380.524 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 8.462 | 132.957 | 6,80 | 4,25 | 35.964 | 565.067 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 30.739 | 1.007.262 | 3,15 | 4,25 | 130.641 | 4.280.864 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 70.807 | 1.011.998 | 7,52 | 4,25 | 300.930 | 4.300.992 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 8.613 | 161.314 | 5,64 | 4,25 | 36.605 | 685.584 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 30.287 | 909.824 | 3,44 | 4,25 | 128.720 | 3.866.752 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 68.093 | 882.664 | 8,36 | 4,25 | 289.395 | 3.751.322 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 8.971 | 160.717 | 5,91 | 4,25 | 38.127 | 683.047 | |
2019-05-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 330.060 | 16.520.814 | 2,04 | 4,25 | 1.402.755 | 70.213.460 | |
2019-05-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 508.617 | 2.091.141 | 32,14 | ||||
2019-05-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 43.887 | 16.190.754 | 0,27 | 4,56 | 200.125 | 73.829.838 | |
2019-04-03 |
|
4 | SYN |
Synthetic Biologics, Inc.
Common Stock |
S - Sale | -69.161 | 165.332 | -29,49 | 0,65 | -44.955 | 107.466 | |
2019-04-03 |
|
4 | SYN |
Synthetic Biologics, Inc.
Common Stock |
S - Sale | -26.080 | 62.342 | -29,49 | 0,65 | -16.952 | 40.522 | |
2019-04-03 |
|
4 | SYN |
Synthetic Biologics, Inc.
Common Stock |
S - Sale | -9.909 | 234.493 | -4,05 | 0,66 | -6.540 | 154.765 | |
2019-04-03 |
|
4 | SYN |
Synthetic Biologics, Inc.
Common Stock |
S - Sale | -3.737 | 88.422 | -4,05 | 0,66 | -2.466 | 58.359 | |
2019-04-03 |
|
4 | SYN |
Synthetic Biologics, Inc.
Common Stock |
S - Sale | -30.265 | 244.402 | -11,02 | 0,67 | -20.278 | 163.749 | |
2019-04-03 |
|
4 | SYN |
Synthetic Biologics, Inc.
Common Stock |
S - Sale | -11.413 | 92.159 | -11,02 | 0,67 | -7.647 | 61.747 | |
2019-04-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 38.022 | 16.146.867 | 0,24 | 5,26 | 199.996 | 84.932.520 | |
2019-03-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 25.094 | 16.108.845 | 0,16 | 7,97 | 199.999 | 128.387.495 | |
2019-02-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 26.109 | 16.083.751 | 0,16 | 7,66 | 199.995 | 123.201.533 | |
2019-01-15 |
|
4 | HSGX |
HISTOGENICS CORP
Common Stock |
S - Sale | -345.897 | 1.692.366 | -16,97 | 0,15 | -51.885 | 253.855 | |
2019-01-15 |
|
4 | HSGX |
HISTOGENICS CORP
Common Stock |
S - Sale | -400.507 | 2.038.263 | -16,42 | 0,16 | -64.081 | 326.122 | |
2019-01-15 |
|
4 | HSGX |
HISTOGENICS CORP
Common Stock |
S - Sale | -251.800 | 2.438.770 | -9,36 | 0,17 | -42.806 | 414.591 | |
2019-01-08 |
|
4 | XON |
INTREXON CORP
Restricted Stock Units |
A - Award | 13.775 | 13.775 | |||||
2019-01-08 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 13.774 | 16.057.642 | 0,09 | ||||
2019-01-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 30.581 | 16.043.868 | 0,19 | 6,54 | 200.000 | 104.926.897 | |
2019-01-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 96.501 | 1.582.524 | 6,49 | 8,29 | 799.993 | 13.119.124 | |
2018-12-03 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 20.408 | 16.013.287 | 0,13 | ||||
2018-12-03 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 77.594 | 1.486.023 | 5,51 | ||||
2018-11-23 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 7.537 | 83.221 | 9,96 | ||||
2018-11-23 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 10.314 | 124.495 | 9,03 | ||||
2018-11-23 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 46.212 | 46.212 | |||||
2018-11-23 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 46.212 | 46.212 | |||||
2018-11-23 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 36.097 | 976.523 | 3,84 | ||||
2018-11-23 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 90.836 | 941.191 | 10,68 | ||||
2018-11-23 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 12.694 | 152.701 | 9,07 | ||||
2018-11-23 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 12.694 | 152.701 | 9,07 | ||||
2018-11-23 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 3.570 | 138.603 | 2,64 | ||||
2018-11-23 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 36.493 | 879.537 | 4,33 | ||||
2018-11-23 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 94.009 | 814.571 | 13,05 | ||||
2018-11-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 17.301 | 15.992.879 | 0,11 | 11,56 | 200.000 | 184.877.681 | |
2018-11-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 55.478 | 1.408.429 | 4,10 | 14,42 | 799.993 | 20.309.546 | |
2018-10-29 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Warrant to Purchase Common Stock |
X - Other | -1.538.461 | 0 | -100,00 | ||||
2018-10-29 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
X - Other | 1.538.461 | 8.239.199 | 22,96 | 2,00 | 3.076.922 | 16.478.398 | |
2018-10-09 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | -130.849 | 0 | -100,00 | ||||
2018-10-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 11.614 | 15.975.578 | 0,07 | 17,22 | 199.993 | 275.099.453 | |
2018-10-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 55.904 | 1.352.951 | 4,31 | 14,31 | 799.986 | 19.360.729 | |
2018-09-28 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1.295 | 130.849 | 1,00 | ||||
2018-09-05 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 13.003 | 15.963.964 | 0,08 | 15,38 | 199.986 | 245.525.766 | |
2018-09-05 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 58.224 | 1.297.047 | 4,70 | 13,74 | 799.998 | 17.821.426 | |
2018-08-31 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1.282 | 129.554 | 1,00 | ||||
2018-08-30 |
|
4 | PRPO |
Precipio, Inc.
Common Stock |
S - Sale | -500 | 27.151 | -1,81 | 0,41 | -205 | 11.132 | |
2018-08-30 |
|
4 | PRPO |
Precipio, Inc.
Common Stock |
S - Sale | -4.920 | 266.904 | -1,81 | 0,41 | -2.017 | 109.431 | |
2018-08-30 |
|
4 | PRPO |
Precipio, Inc.
Common Stock |
S - Sale | -9.340 | 506.657 | -1,81 | 0,41 | -3.829 | 207.729 | |
2018-08-30 |
|
4 | PRPO |
Precipio, Inc.
Common Stock |
S - Sale | -9.840 | 533.809 | -1,81 | 0,41 | -4.034 | 218.862 | |
2018-08-28 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -256.860 | 1.897.610 | -11,92 | 18,02 | -4.628.617 | 34.194.932 | |
2018-08-28 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -175.389 | 3.900.919 | -4,30 | 18,02 | -3.160.510 | 70.294.560 | |
2018-08-28 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -64.996 | 2.154.470 | -2,93 | 18,22 | -1.184.227 | 39.254.443 | |
2018-08-28 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -44.381 | 4.076.308 | -1,08 | 18,22 | -808.622 | 74.270.332 | |
2018-08-28 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -61.428 | 2.219.466 | -2,69 | 18,20 | -1.117.990 | 40.394.281 | |
2018-08-28 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -41.944 | 4.120.689 | -1,01 | 18,20 | -763.381 | 74.996.540 | |
2018-08-23 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -149.353 | 2.280.894 | -6,15 | 18,48 | -2.760.043 | 42.150.921 | |
2018-08-23 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -101.982 | 4.162.633 | -2,39 | 18,48 | -1.884.627 | 76.925.458 | |
2018-08-23 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -464.624 | 2.430.247 | -16,05 | 17,49 | -8.126.274 | 42.505.020 | |
2018-08-23 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -317.257 | 4.264.615 | -6,92 | 17,49 | -5.548.825 | 74.588.116 | |
2018-08-23 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -95.819 | 2.894.871 | -3,20 | 17,15 | -1.643.296 | 49.647.038 | |
2018-08-23 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -65.427 | 4.581.872 | -1,41 | 17,15 | -1.122.073 | 78.579.105 | |
2018-08-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -56.668 | 2.985.054 | -1,86 | 17,24 | -976.956 | 51.462.331 | |
2018-08-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -38.695 | 4.643.451 | -0,83 | 17,24 | -667.102 | 80.053.095 | |
2018-08-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -54.397 | 3.041.722 | -1,76 | 17,15 | -932.909 | 52.165.532 | |
2018-08-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -37.144 | 4.682.146 | -0,79 | 17,15 | -637.020 | 80.298.804 | |
2018-08-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -180.154 | 3.096.119 | -5,50 | 17,36 | -3.127.473 | 53.748.626 | |
2018-08-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -123.014 | 4.719.290 | -2,54 | 17,36 | -2.135.523 | 81.926.874 | |
2018-08-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -120.606 | 3.276.273 | -3,55 | 17,08 | -2.059.950 | 55.958.743 | |
2018-08-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -82.353 | 4.842.304 | -1,67 | 17,08 | -1.406.589 | 82.706.552 | |
2018-08-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -132.591 | 3.396.879 | -3,76 | 17,48 | -2.317.691 | 59.377.445 | |
2018-08-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -90.536 | 4.924.657 | -1,81 | 17,48 | -1.582.569 | 86.083.004 | |
2018-08-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -87.185 | 3.529.470 | -2,41 | 17,52 | -1.527.481 | 61.836.314 | |
2018-08-10 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -59.533 | 5.015.193 | -1,17 | 17,52 | -1.043.018 | 87.866.181 | |
2018-08-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 13.642 | 15.950.961 | 0,09 | 14,66 | 199.992 | 233.841.088 | |
2018-08-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 52.015 | 1.238.823 | 4,38 | 15,38 | 799.991 | 19.053.098 | |
2018-07-31 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1.270 | 128.272 | 1,00 | ||||
2018-07-27 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -29.074 | 3.616.655 | -0,80 | 16,90 | -491.351 | 61.121.470 | |
2018-07-27 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -19.853 | 5.074.726 | -0,39 | 16,90 | -335.516 | 85.762.869 | |
2018-07-27 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -89.136 | 3.645.729 | -2,39 | 17,30 | -1.542.053 | 63.071.112 | |
2018-07-27 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -60.864 | 5.094.579 | -1,18 | 17,30 | -1.052.947 | 88.136.217 | |
2018-07-27 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -61.741 | 3.734.865 | -1,63 | 17,32 | -1.069.354 | 64.687.862 | |
2018-07-27 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -42.159 | 5.155.443 | -0,81 | 17,32 | -730.194 | 89.292.273 | |
2018-07-06 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1.121.914 | 15.937.319 | 7,57 | 13,37 | 14.999.990 | 213.081.955 | |
2018-07-06 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 6.357.517 | 14.140.139 | 81,69 | 13,37 | 85.000.002 | 189.053.658 | |
2018-07-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 14.347 | 14.815.405 | 0,10 | 13,94 | 199.997 | 206.526.746 | |
2018-07-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 49.535 | 1.186.808 | 4,36 | 16,15 | 799.990 | 19.166.949 | |
2018-06-29 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1.257 | 127.002 | 1,00 | ||||
2018-06-29 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -72.753 | 3.796.606 | -1,88 | 16,97 | -1.234.618 | 64.428.404 | |
2018-06-29 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -49.678 | 5.197.602 | -0,95 | 16,97 | -843.036 | 88.203.306 | |
2018-06-29 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -76.291 | 3.869.359 | -1,93 | 16,99 | -1.296.184 | 65.740.409 | |
2018-06-29 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -52.094 | 5.247.280 | -0,98 | 16,99 | -885.077 | 89.151.287 | |
2018-06-29 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -31.795 | 3.945.650 | -0,80 | 17,34 | -551.325 | 68.417.571 | |
2018-06-29 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
S - Sale | -21.710 | 5.299.374 | -0,41 | 17,34 | -376.451 | 91.891.145 | |
2018-06-04 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1.245 | 125.745 | 1,00 | ||||
2018-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 12.062 | 14.801.058 | 0,08 | 16,58 | 199.988 | 245.401.542 | |
2018-06-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 49.382 | 1.137.273 | 4,54 | 16,20 | 799.988 | 18.423.823 | |
2018-05-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 11.001 | 14.788.996 | 0,07 | 18,18 | 199.998 | 268.863.947 | |
2018-05-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 40.774 | 1.087.891 | 3,89 | 19,62 | 799.986 | 21.344.421 | |
2018-04-30 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1.232 | 124.500 | 1,00 | ||||
2018-04-03 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 13.046 | 14.777.995 | 0,09 | 15,33 | 199.995 | 226.546.663 | |
2018-04-03 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 47.505 | 1.047.117 | 4,75 | 16,84 | 799.984 | 17.633.450 | |
2018-03-30 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1.220 | 123.268 | 1,00 | ||||
2018-03-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 15.360 | 14.764.949 | 0,10 | 13,02 | 199.987 | 192.239.636 | |
2018-03-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 58.737 | 999.612 | 6,24 | 13,62 | 799.998 | 13.614.715 | |
2018-02-28 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1.208 | 122.048 | 1,00 | ||||
2018-02-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 15.384 | 14.749.589 | 0,10 | 13,00 | 199.992 | 191.744.657 | |
2018-02-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 54.384 | 940.875 | 6,13 | 14,71 | 799.989 | 13.840.271 | |
2018-01-31 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1.196 | 120.840 | 1,00 | ||||
2018-01-22 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 1.000.000 | 7.782.622 | 14,74 | 12,50 | 12.500.000 | 97.282.775 | |
2018-01-19 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Warrant to Purchase Common Stock |
P - Purchase | 1.538.461 | 1.538.461 | |||||
2018-01-19 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
P - Purchase | 1.538.461 | 6.700.738 | 29,80 | 3,25 | 4.999.998 | 21.777.398 | |
2018-01-03 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1.184 | 119.644 | 1,00 | ||||
2018-01-03 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Option to Purchase Common Stock |
A - Award | 25.000 | 25.000 | |||||
2018-01-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 63.291 | 886.491 | 7,69 | 12,64 | 799.998 | 11.205.246 | |
2018-01-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 17.361 | 14.734.205 | 0,12 | 11,52 | 199.999 | 169.738.042 | |
2018-01-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 1.207.980 | 14.716.844 | 8,94 | 11,33 | 13.686.413 | 166.741.843 | |
2017-12-13 |
|
4 | FCSC |
Fibrocell Science, Inc.
Warrant to Purchase Common Stock |
P - Purchase | 4.805 | 4.805 | |||||
2017-12-13 |
|
4 | FCSC |
Fibrocell Science, Inc.
Warrant to Purchase Common Stock |
P - Purchase | 155.347 | 155.347 | |||||
2017-12-13 |
|
4 | FCSC |
Fibrocell Science, Inc.
Warrant to Purchase Common Stock |
P - Purchase | 2.567.121 | 2.567.121 | |||||
2017-12-13 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
P - Purchase | 4.805 | 10.806 | 80,07 | 0,77 | 3.700 | 8.321 | |
2017-12-13 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
P - Purchase | 155.347 | 349.386 | 80,06 | 0,77 | 119.617 | 269.027 | |
2017-12-13 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
P - Purchase | 2.567.121 | 5.773.626 | 80,06 | 0,77 | 1.976.683 | 4.445.692 | |
2017-12-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 14.662 | 13.508.864 | 0,11 | 13,64 | 199.990 | 184.260.905 | |
2017-12-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 63.241 | 823.200 | 8,32 | 12,65 | 799.999 | 10.413.480 | |
2017-11-30 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1.172 | 118.460 | 1,00 | ||||
2017-11-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 12.232 | 13.494.202 | 0,09 | 16,35 | 199.993 | 220.630.203 | |
2017-11-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 44.469 | 759.959 | 6,22 | 17,99 | 799.997 | 13.671.662 | |
2017-11-01 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1.161 | 117.288 | 1,00 | ||||
2017-10-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 10.520 | 13.481.970 | 0,08 | 19,01 | 199.985 | 256.292.250 | |
2017-10-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 41.300 | 715.490 | 6,13 | 19,37 | 799.981 | 13.859.041 | |
2017-09-29 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1.149 | 116.127 | 1,00 | ||||
2017-09-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 10.136 | 13.471.450 | 0,08 | 19,73 | 199.983 | 265.791.708 | |
2017-09-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 42.941 | 674.190 | 6,80 | 18,63 | 799.991 | 12.560.160 | |
2017-08-31 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1.138 | 114.978 | 1,00 | ||||
2017-08-30 |
|
4 | PRPO |
Precipio, Inc.
Warrant to Purchase Common Stock |
P - Purchase | 80.292 | 80.292 | |||||
2017-08-30 |
|
4 | PRPO |
Precipio, Inc.
Series A Senior Convertible Preferred Stock |
C - Conversion | -162.696 | 0 | -100,00 | ||||
2017-08-30 |
|
4 | PRPO |
Precipio, Inc.
Warrant to Purchase Common Stock |
P - Purchase | 160.585 | 160.585 | |||||
2017-08-30 |
|
4 | PRPO |
Precipio, Inc.
Warrant to Purchase Common Stock |
P - Purchase | 160.585 | 160.585 | |||||
2017-08-30 |
|
4 | PRPO |
Precipio, Inc.
Series A Senior Convertible Preferred Stock |
C - Conversion | -325.393 | 0 | -100,00 | ||||
2017-08-30 |
|
4 | PRPO |
Precipio, Inc.
Series A Senior Convertible Preferred Stock |
C - Conversion | -325.393 | 0 | -100,00 | ||||
2017-08-30 |
|
4 | PRPO |
Precipio, Inc.
Common Stock |
C - Conversion | 162.696 | 271.824 | 149,09 | ||||
2017-08-30 |
|
4 | PRPO |
Precipio, Inc.
Common Stock |
C - Conversion | 325.393 | 515.997 | 170,72 | ||||
2017-08-30 |
|
4 | PRPO |
Precipio, Inc.
Common Stock |
C - Conversion | 325.393 | 515.997 | 170,72 | ||||
2017-08-14 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 132.625 | 6.782.622 | 1,99 | 18,85 | 2.499.981 | 127.852.425 | |
2017-08-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 9.263 | 13.461.314 | 0,07 | 21,59 | 199.988 | 290.629.769 | |
2017-08-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 34.587 | 631.249 | 5,80 | 23,13 | 799.997 | 14.600.789 | |
2017-07-31 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1.127 | 113.840 | 1,00 | ||||
2017-07-26 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 8.325.000 | 8.325.000 | |||||
2017-07-26 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 8.099.238 | 13.452.051 | 151,31 | ||||
2017-07-26 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | -22.636.052 | 0 | -100,00 | ||||
2017-07-26 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | 2.327.603 | 2.327.603 | |||||
2017-07-26 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | 2.264.483 | 5.321.084 | 74,09 | ||||
2017-07-26 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | -6.328.853 | 0 | -100,00 | ||||
2017-07-26 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 124.609 | 124.609 | |||||
2017-07-26 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 121.231 | 200.519 | 152,90 | ||||
2017-07-26 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | -338.816 | 0 | -100,00 | ||||
2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Convertible Promissory Note |
C - Conversion | 0 | ||||||
2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Series A-1 Convertible Preferred Stock |
C - Conversion | -42.941 | 0 | -100,00 | ||||
2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Series A-1 Convertible Preferred Stock |
C - Conversion | -42.941 | 0 | -100,00 | ||||
2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Series A Senior Convertible Preferred Stock |
P - Purchase | 160.585 | 160.585 | 3,74 | 600.588 | 600.588 | ||
2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Convertible Promissory Note |
C - Conversion | 160.585 | ||||||
2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Convertible Promissory Note |
C - Conversion | 70.526 | ||||||
2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Series A-1 Convertible Preferred Stock |
C - Conversion | -42.941 | 0 | -100,00 | ||||
2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Series A Senior Convertible Preferred Stock |
P - Purchase | 321.170 | 321.170 | 3,74 | 1.201.176 | 1.201.176 | ||
2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Series A Senior Convertible Preferred Stock |
P - Purchase | 321.170 | 321.170 | 3,74 | 1.201.176 | 1.201.176 | ||
2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Convertible Promissory Note |
C - Conversion | 321.170 | ||||||
2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Convertible Promissory Note |
C - Conversion | 141.052 | ||||||
2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Series A-1 Convertible Preferred Stock |
C - Conversion | -85.882 | 0 | -100,00 | ||||
2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Convertible Promissory Note |
C - Conversion | 321.170 | ||||||
2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Common Stock |
C - Conversion | 1.431 | 27.651 | 5,46 | ||||
2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Common Stock |
C - Conversion | 1.431 | 27.651 | 5,46 | ||||
2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Common Stock |
C - Conversion | 1.431 | 27.651 | 5,46 | ||||
2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Common Stock |
C - Conversion | 70.526 | 107.697 | 189,73 | 15,00 | 1.057.890 | 1.615.455 | |
2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Common Stock |
C - Conversion | 141.052 | 189.173 | 293,12 | 15,00 | 2.115.780 | 2.837.595 | |
2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Common Stock |
C - Conversion | 141.052 | 189.173 | 293,12 | 15,00 | 2.115.780 | 2.837.595 | |
2017-07-03 |
|
4 | TBIO |
Precipio, Inc.
Common Stock |
C - Conversion | 2.862 | 218.256 | 1,33 | ||||
2017-06-30 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1.115 | 112.713 | 1,00 | ||||
2017-06-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 8.302 | 5.352.813 | 0,16 | 24,09 | 199.995 | 128.949.265 | |
2017-06-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 35.056 | 596.662 | 6,24 | 22,82 | 799.978 | 13.615.827 | |
2017-06-12 |
|
4 | TBIO |
TRANSGENOMIC INC
Common Stock |
S - Sale | -108.000 | 786.613 | -12,07 | 1,00 | -108.000 | 786.613 | |
2017-06-12 |
|
4 | TBIO |
TRANSGENOMIC INC
Common Stock |
S - Sale | -395.000 | 1.115.135 | -26,16 | 1,00 | -395.000 | 1.115.135 | |
2017-06-12 |
|
4 | TBIO |
TRANSGENOMIC INC
Common Stock |
S - Sale | -682.000 | 1.443.654 | -32,08 | 1,00 | -682.000 | 1.443.654 | |
2017-06-12 |
|
4 | TBIO |
TRANSGENOMIC INC
Common Stock |
S - Sale | -790.000 | 2.230.267 | -26,16 | 1,00 | -790.000 | 2.230.267 | |
2017-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 9.380 | 5.344.511 | 0,18 | 21,32 | 199.982 | 113.944.975 | |
2017-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 31.164 | 561.606 | 5,88 | 25,67 | 799.980 | 14.416.426 | |
2017-06-01 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1.104 | 111.598 | 1,00 | ||||
2017-05-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock |
M - Exercise | -10.000 | 0 | -100,00 | ||||
2017-05-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
M - Exercise | 10.000 | 3.562.388 | 0,28 | 10,37 | 103.700 | 36.941.964 | |
2017-05-08 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
A - Award | 14.135 | 3.552.388 | 0,40 | ||||
2017-05-08 |
|
4 | SNGX |
SOLIGENIX, INC.
Common Stock |
S - Sale | -1.881 | 85.397 | -2,16 | 2,54 | -4.778 | 216.908 | |
2017-05-08 |
|
4 | SNGX |
SOLIGENIX, INC.
Common Stock |
S - Sale | -9.695 | 440.418 | -2,15 | 2,54 | -24.625 | 1.118.662 | |
2017-05-08 |
|
4 | SNGX |
SOLIGENIX, INC.
Common Stock |
S - Sale | -13.893 | 87.278 | -13,73 | 2,70 | -37.511 | 235.651 | |
2017-05-08 |
|
4 | SNGX |
SOLIGENIX, INC.
Common Stock |
S - Sale | -71.607 | 450.113 | -13,73 | 2,70 | -193.339 | 1.215.305 | |
2017-05-08 |
|
4 | SNGX |
SOLIGENIX, INC.
Warrant to Purchase Common Stock |
X - Other | -250.000 | 0 | -100,00 | ||||
2017-05-08 |
|
4 | SNGX |
SOLIGENIX, INC.
Common Stock |
S - Sale | -2.278 | 101.171 | -2,20 | 2,97 | -6.766 | 300.478 | |
2017-05-08 |
|
4 | SNGX |
SOLIGENIX, INC.
Common Stock |
S - Sale | -11.739 | 521.720 | -2,20 | 2,97 | -34.865 | 1.549.508 | |
2017-05-08 |
|
4 | SNGX |
SOLIGENIX, INC.
Common Stock |
S - Sale | -49.875 | 533.459 | -8,55 | 4,01 | -199.999 | 2.139.171 | |
2017-05-08 |
|
4 | SNGX |
SOLIGENIX, INC.
Common Stock |
X - Other | 250.000 | 583.334 | 75,00 | 0,80 | 200.000 | 466.667 | |
2017-05-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 9.596 | 5.335.131 | 0,18 | 20,84 | 199.981 | 111.184.130 | |
2017-05-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 40.671 | 530.442 | 8,30 | 19,67 | 799.999 | 10.433.794 | |
2017-05-02 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1.094 | 110.494 | 1,00 | ||||
2017-04-03 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 10.090 | 5.325.535 | 0,19 | 19,82 | 199.984 | 105.552.104 | |
2017-04-03 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 37.807 | 489.771 | 8,37 | 21,16 | 799.996 | 10.363.554 | |
2017-03-31 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1.083 | 109.400 | 1,00 | ||||
2017-03-10 |
|
4 | FCSC |
Fibrocell Science, Inc.
Warrant to Purchase Common Stock |
P - Purchase | 1.496.529 | 1.496.529 | |||||
2017-03-10 |
|
4 | FCSC |
Fibrocell Science, Inc.
Warrant to Purchase Common Stock |
P - Purchase | 2.250.594 | 2.250.594 | |||||
2017-03-10 |
|
4 | FCSC |
Fibrocell Science, Inc.
Warrant to Purchase Common Stock |
P - Purchase | 3.867 | 3.867 | |||||
2017-03-10 |
|
4 | FCSC |
Fibrocell Science, Inc.
Warrant to Purchase Common Stock |
P - Purchase | 136.634 | 136.634 | |||||
2017-03-10 |
|
4 | FCSC |
Fibrocell Science, Inc.
Series A Convertible Preferred |
P - Purchase | 1.161 | 1.496.529 | 0,08 | ||||
2017-03-10 |
|
4 | FCSC |
Fibrocell Science, Inc.
Series A Convertible Preferred |
P - Purchase | 1.746 | 2.250.594 | 0,08 | ||||
2017-03-10 |
|
4 | FCSC |
Fibrocell Science, Inc.
Series A Convertible Preferred |
P - Purchase | 3 | 3.867 | 0,08 | ||||
2017-03-10 |
|
4 | FCSC |
Fibrocell Science, Inc.
Series A Convertible Preferred |
P - Purchase | 106 | 136.634 | 0,08 | ||||
2017-03-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
G - Gift | -200 | 5.315.445 | 0,00 | ||||
2017-03-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 8.984 | 5.315.645 | 0,17 | 22,26 | 199.984 | 118.326.258 | |
2017-03-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 33.826 | 451.964 | 8,09 | 23,65 | 799.985 | 10.688.949 | |
2017-03-02 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1.072 | 108.317 | 1,00 | ||||
2017-02-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 9.451 | 5.306.661 | 0,18 | 21,16 | 199.983 | 112.288.947 | |
2017-02-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 32.297 | 418.138 | 8,37 | 24,77 | 799.997 | 10.357.278 | |
2017-02-02 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1.061 | 107.245 | 1,00 | ||||
2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 3.637 | 3.637 | |||||
2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 199.682 | 199.682 | |||||
2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 338.816 | 338.816 | |||||
2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 10.153 | 10.153 | |||||
2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 20.306 | 20.306 | |||||
2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 20.306 | 20.306 | |||||
2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 14.076 | 14.076 | |||||
2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 3.199 | 3.199 | |||||
2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 880 | 880 | |||||
2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 82.083 | 82.083 | |||||
2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 99.537 | 99.537 | |||||
2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 295 | 295 | |||||
2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 885 | 885 | |||||
2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 1.770 | 1.770 | |||||
2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 2.021 | 2.021 | |||||
2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 12.617 | 12.617 | |||||
2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 1.132 | 1.132 | |||||
2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 12.726 | 12.726 | |||||
2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 10.784 | 10.784 | |||||
2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 1.708 | 1.708 | |||||
2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 2.095 | 2.095 | |||||
2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 2.080 | 2.080 | |||||
2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 20 | 20 | |||||
2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 4.659 | 4.659 | |||||
2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 79.288 | 79.288 | |||||
2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | 5.775 | 5.775 | |||||
2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
P - Purchase | 2.421.073 | 5.161.247 | 88,35 | 10,33 | 25.009.684 | 53.315.682 | |
2017-01-20 |
|
4 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
J - Other | -1.776.557 | 2.740.174 | -39,33 | ||||
2017-01-05 | 3 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
271.003.808 | ||||||||
2017-01-05 | 3 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
271.003.808 | ||||||||
2017-01-05 | 3 | AQB |
AquaBounty Technologies, Inc.
Common Stock |
271.003.808 | ||||||||
2016-12-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 8.230 | 5.297.210 | 0,16 | 24,30 | 199.989 | 128.722.203 | |
2016-12-30 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 28.188 | 385.841 | 7,88 | 28,38 | 799.975 | 10.950.168 | |
2016-12-30 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1.051 | 106.184 | 1,00 | ||||
2016-12-30 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
A - Award | 17.204 | 139.513 | 14,07 | ||||
2016-12-29 |
|
4 | APHB |
AmpliPhi Biosciences Corp
Common Stock |
S - Sale | -20.077 | 674.169 | -2,89 | 0,45 | -9.035 | 303.376 | |
2016-12-29 |
|
4 | APHB |
AmpliPhi Biosciences Corp
Common Stock |
S - Sale | -21.923 | 736.170 | -2,89 | 0,45 | -9.865 | 331.276 | |
2016-12-29 |
|
4 | APHB |
AmpliPhi Biosciences Corp
Common Stock |
S - Sale | -40.450 | 694.246 | -5,51 | 0,47 | -19.012 | 326.296 | |
2016-12-29 |
|
4 | APHB |
AmpliPhi Biosciences Corp
Common Stock |
S - Sale | -44.170 | 758.093 | -5,51 | 0,47 | -20.760 | 356.304 | |
2016-12-29 |
|
4 | APHB |
AmpliPhi Biosciences Corp
Common Stock |
S - Sale | -24.092 | 734.696 | -3,18 | 0,51 | -12.287 | 374.695 | |
2016-12-29 |
|
4 | APHB |
AmpliPhi Biosciences Corp
Common Stock |
S - Sale | -26.308 | 802.263 | -3,18 | 0,51 | -13.417 | 409.154 | |
2016-12-14 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 34.606 | 213.805 | 19,31 | 28,90 | 1.000.113 | 6.178.964 | |
2016-12-01 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1.040 | 105.133 | 1,00 | ||||
2016-12-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 6.854 | 5.288.980 | 0,13 | 29,18 | 200.000 | 154.332.436 | |
2016-12-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 24.494 | 357.653 | 7,35 | 32,66 | 799.974 | 11.680.947 | |
2016-11-16 |
|
4 | APHB |
AmpliPhi Biosciences Corp
Series B Preferred Stock |
C - Conversion | -2.142.857 | 0 | -100,00 | ||||
2016-11-16 |
|
4 | APHB |
AmpliPhi Biosciences Corp
Common Stock |
C - Conversion | 428.571 | 828.571 | 107,14 | ||||
2016-11-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 7.662 | 5.282.126 | 0,15 | 26,10 | 199.978 | 137.863.489 | |
2016-11-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 29.985 | 333.159 | 9,89 | 26,68 | 800.000 | 8.888.682 | |
2016-11-02 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1.030 | 104.093 | 1,00 | ||||
2016-10-04 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1.020 | 103.063 | 1,00 | ||||
2016-10-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 7.137 | 5.274.464 | 0,14 | 28,02 | 199.979 | 147.790.481 | |
2016-10-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 29.154 | 303.174 | 10,64 | 27,44 | 799.986 | 8.319.095 | |
2016-09-09 |
|
4 | FCSC |
Fibrocell Science, Inc.
Convertible Promissory Note |
P - Purchase | 2.604.345 | ||||||
2016-09-09 |
|
4 | FCSC |
Fibrocell Science, Inc.
Warrant to Purchase Common Stock |
P - Purchase | 2.604.345 | 2.604.345 | |||||
2016-09-09 |
|
4 | FCSC |
Fibrocell Science, Inc.
Warrant to Purchase Common Stock |
P - Purchase | 3.913.979 | 3.913.979 | |||||
2016-09-09 |
|
4 | FCSC |
Fibrocell Science, Inc.
Warrant to Purchase Common Stock |
P - Purchase | 7.325 | 7.325 | |||||
2016-09-09 |
|
4 | FCSC |
Fibrocell Science, Inc.
Warrant to Purchase Common Stock |
P - Purchase | 236.851 | 236.851 | |||||
2016-09-09 |
|
4 | FCSC |
Fibrocell Science, Inc.
Convertible Promissory Note |
P - Purchase | |||||||
2016-09-09 |
|
4 | FCSC |
Fibrocell Science, Inc.
Convertible Promissory Note |
P - Purchase | |||||||
2016-09-09 |
|
4 | FCSC |
Fibrocell Science, Inc.
Convertible Promissory Note |
P - Purchase | |||||||
2016-09-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 7.923 | 5.267.327 | 0,15 | 25,24 | 199.977 | 132.947.333 | |
2016-09-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 27.586 | 274.020 | 11,19 | 29,00 | 799.994 | 7.946.580 | |
2016-09-02 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1.010 | 102.043 | 1,00 | ||||
2016-08-18 |
|
4 | XON |
INTREXON CORP
Option to Purchase Common Stock |
X - Other | -2.957 | 0 | -100,00 | ||||
2016-08-18 |
|
4 | XON |
INTREXON CORP
Option to Purchase Common Stock |
X - Other | -8.871 | 0 | -100,00 | ||||
2016-08-18 |
|
4 | XON |
INTREXON CORP
Common Stock |
X - Other | 2.957 | 5.259.404 | 0,06 | 3,18 | 9.403 | 16.724.905 | |
2016-08-18 |
|
4 | XON |
INTREXON CORP
Common Stock |
X - Other | 8.871 | 5.256.447 | 0,17 | 2,65 | 23.508 | 13.929.585 | |
2016-08-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 7.895 | 5.247.576 | 0,15 | 25,33 | 199.980 | 132.921.100 | |
2016-08-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 32.586 | 246.434 | 15,24 | 24,55 | 799.986 | 6.049.955 | |
2016-08-02 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
J - Other | 1.033 | 101.033 | 1,03 | ||||
2016-07-06 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Series 1 Preferred Stock |
P - Purchase | 100.000 | 100.000 | |||||
2016-07-05 |
|
4 | OGEN |
ORAGENICS INC
Common Stock |
P - Purchase | 2.261.419 | 14.481.089 | 18,51 | 0,52 | 1.166.666 | 7.470.794 | |
2016-07-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 8.126 | 5.239.681 | 0,16 | 24,61 | 199.981 | 128.948.549 | |
2016-07-01 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 31.372 | 213.848 | 17,19 | 25,50 | 799.986 | 5.453.124 | |
2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 19.711 | 19.711 | |||||
2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 59.133 | 59.133 | |||||
2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 118.266 | 118.266 | |||||
2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 3.952 | 135.033 | 3,01 | ||||
2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 24.583 | 843.044 | 3,00 | ||||
2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 2.016 | 75.684 | 2,74 | ||||
2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 20.976 | 850.355 | 2,53 | ||||
2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 20.976 | 850.355 | 2,53 | ||||
2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 8.977 | 158.885.269 | 0,01 | ||||
2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 8.977 | 114.181 | 8,53 | ||||
2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 8.977 | 114.181 | 8,53 | ||||
2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 335 | 1.403 | 31,37 | ||||
2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 73.763 | 311.287 | 31,05 | ||||
2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 334.737 | 5.231.555 | 6,84 | ||||
2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | -1.196.077 | 0 | -100,00 | ||||
2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 6.506 | 4.896.818 | 0,13 | 30,74 | 199.994 | 150.528.185 | |
2016-06-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 32.854 | 182.476 | 21,96 | 24,35 | 799.995 | 4.443.291 | |
2016-06-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | 21.858 | 21.858 | |||||
2016-06-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | 65.572 | 65.572 | |||||
2016-06-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | 131.144 | 131.144 | |||||
2016-06-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | 4.382 | 46.701 | 10,35 | ||||
2016-06-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | 27.260 | 290.460 | 10,36 | ||||
2016-06-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | 2.235 | 2.235 | |||||
2016-06-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | 23.259 | 354.653 | 7,02 | ||||
2016-06-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | 23.259 | 354.653 | 7,02 | ||||
2016-06-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | 9.954 | 41.836.607 | 0,02 | ||||
2016-06-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | 9.954 | 302.954 | 3,40 | ||||
2016-06-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | 9.954 | 302.954 | 3,40 | ||||
2016-06-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | 372 | 11.317 | 3,40 | ||||
2016-06-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | 371.186 | 3.056.601 | 13,82 | ||||
2016-06-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | 81.795 | 216.795 | 60,59 | ||||
2016-06-02 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
J - Other | -1.326.320 | 0 | -100,00 | ||||
2016-05-16 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 41.830 | 6.649.997 | 0,63 | 23,92 | 1.000.574 | 159.067.928 | |
2016-05-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
A - Award | 20.202 | 3.538.253 | 0,57 | ||||
2016-05-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 21.074 | 149.622 | 16,39 | 37,96 | 799.969 | 5.679.651 | |
2016-05-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 7.482 | 4.890.312 | 0,15 | 26,73 | 199.994 | 130.718.040 | |
2016-04-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 23.398 | 128.548 | 22,25 | 34,19 | 799.978 | 4.395.056 | |
2016-04-04 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 5.901 | 4.882.830 | 0,12 | 33,89 | 199.985 | 165.479.109 | |
2016-03-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 26.963 | 105.150 | 34,49 | 29,67 | 799.992 | 3.119.800 | |
2016-03-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 6.462 | 4.876.929 | 0,13 | 30,95 | 199.999 | 150.940.953 | |
2016-02-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 29.509 | 78.187 | 60,62 | 27,11 | 799.989 | 2.119.650 | |
2016-02-02 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 6.863 | 4.870.467 | 0,14 | 29,14 | 199.988 | 141.925.408 | |
2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Warrant to Purchase Common Stock |
P - Purchase | 32.205 | 32.205 | |||||
2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Warrant to Purchase Common Stock |
P - Purchase | 32.205 | 32.205 | |||||
2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Series A-1 Convertible Preferred Stock |
P - Purchase | 42.941 | 42.941 | |||||
2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Series A-1 Convertible Preferred Stock |
P - Purchase | 42.941 | 42.941 | |||||
2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Warrant to Purchase Common Stock |
P - Purchase | 32.205 | 32.205 | |||||
2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Series A-1 Convertible Preferred Stock |
P - Purchase | 42.941 | 42.941 | |||||
2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Warrant to Purchase Common Stock |
P - Purchase | 64.411 | 64.411 | |||||
2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Series A-1 Convertible Preferred Stock |
P - Purchase | 85.882 | 85.882 | |||||
2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Series B Convertible Preferred Stock |
C - Conversion | -577.319 | 0 | -100,00 | ||||
2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Series B Convertible Preferred Stock |
C - Conversion | -577.319 | 0 | -100,00 | ||||
2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Series B Convertible Preferred Stock |
C - Conversion | -288.659 | 0 | -100,00 | ||||
2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Series A Convertible Preferred Stock |
C - Conversion | -517.241 | 0 | -100,00 | ||||
2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Series A Convertible Preferred Stock |
C - Conversion | -1.034.482 | 0 | -100,00 | ||||
2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Series A Convertible Preferred Stock |
C - Conversion | -1.034.482 | 0 | -100,00 | ||||
2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Common Stock |
P - Purchase | 317.294 | 894.613 | 54,96 | 1,00 | 317.294 | 894.613 | |
2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Common Stock |
C - Conversion | 577.319 | 577.319 | |||||
2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Common Stock |
P - Purchase | 894.965 | 1.510.135 | 145,48 | 1,00 | 894.965 | 1.510.135 | |
2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Common Stock |
C - Conversion | 461.072 | 615.170 | 299,21 | ||||
2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Common Stock |
P - Purchase | 1.472.636 | 2.125.654 | 225,51 | 1,00 | 1.472.636 | 2.125.654 | |
2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Common Stock |
C - Conversion | 344.822 | 653.018 | 111,88 | ||||
2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Common Stock |
P - Purchase | 1.789.930 | 3.020.267 | 145,48 | 1,00 | 1.789.930 | 3.020.267 | |
2016-01-11 |
|
4 | TBIO |
TRANSGENOMIC INC
Common Stock |
C - Conversion | 922.141 | 1.230.337 | 299,21 | ||||
2016-01-05 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 26.041 | 48.678 | 115,04 | 30,72 | 799.980 | 1.495.388 | |
2016-01-05 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 6.633 | 4.863.604 | 0,14 | 30,15 | 199.985 | 146.637.661 | |
2016-01-04 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
A - Award | 26.661 | 122.309 | 27,87 | ||||
2015-12-14 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 34.100 | 6.608.167 | 0,52 | 29,83 | 1.017.203 | 197.121.622 | |
2015-12-14 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 90.375 | 6.574.067 | 1,39 | 29,86 | 2.698.598 | 196.301.641 | |
2015-12-07 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 237.525 | 6.483.692 | 3,80 | 30,69 | 7.289.642 | 198.984.507 | |
2015-12-03 |
|
4 | OGEN |
ORAGENICS INC
Convertible Promissory Note |
C - Conversion | 0 | ||||||
2015-12-03 |
|
4 | OGEN |
ORAGENICS INC
Common Stock |
C - Conversion | 3.381.004 | 12.219.670 | 38,25 | 1,50 | 5.071.506 | 18.329.505 | |
2015-12-03 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 22.637 | 22.637 | 35,34 | 799.992 | 799.992 | ||
2015-12-03 |
|
4 | XON |
INTREXON CORP
Common Stock |
G - Gift | -200 | 4.856.971 | 0,00 | ||||
2015-12-03 |
|
4 | XON |
INTREXON CORP
Common Stock |
A - Award | 5.508 | 4.857.171 | 0,11 | 36,31 | 199.995 | 176.363.879 | |
2015-09-04 |
|
4 | SYN |
Synthetic Biologics, Inc.
Common Stock |
P - Purchase | 937.500 | 9.613.268 | 10,81 | 3,20 | 3.000.000 | 30.762.458 | |
2015-07-27 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
P - Purchase | 375.868 | 6.400.783 | 6,24 | 5,80 | 2.180.034 | 37.124.541 | |
2015-07-27 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
P - Purchase | 18.003 | 18.003 | 5,80 | 104.417 | 104.417 | ||
2015-07-27 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
P - Purchase | 582.116 | 582.116 | 5,80 | 3.376.273 | 3.376.273 | ||
2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 86.556 | 86.556 | |||||
2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 173.111 | 173.111 | |||||
2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 58.746 | 58.746 | |||||
2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 176.238 | 176.238 | |||||
2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 352.477 | 352.477 | |||||
2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 111.339 | 111.339 | |||||
2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 222.680 | 222.680 | |||||
2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 395.791 | 395.791 | |||||
2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 889.513 | 889.513 | |||||
2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 1.013.146 | 2.359.608 | 75,25 | ||||
2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 61.262 | 61.262 | |||||
2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 138.975 | 138.975 | |||||
2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 154.181 | 154.181 | |||||
2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 29.066 | 29.066 | |||||
2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 34.318 | 34.318 | |||||
2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 358.386 | 358.386 | |||||
2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 337.333 | 337.333 | |||||
2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 9.537 | 9.537 | |||||
2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 53.245 | 53.245 | |||||
2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 240 | 240 | |||||
2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 40.954 | 40.954 | |||||
2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 23.504 | 23.504 | |||||
2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 23.349 | 23.349 | |||||
2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | 3.479.006 | 3.479.006 | |||||
2015-06-08 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
J - Other | -17.830.305 | 0 | -100,00 | ||||
2015-05-08 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
A - Award | 13.175 | 3.518.051 | 0,38 | ||||
2015-03-18 |
|
4 | APHB |
AmpliPhi Biosciences Corp
Warrant to Purchase Common Stock |
P - Purchase | 3.484.848 | 3.484.848 | |||||
2015-03-18 |
|
4 | APHB |
AmpliPhi Biosciences Corp
Common Stock |
P - Purchase | 13.939.392 | 37.939.392 | 58,08 | 0,16 | 2.300.000 | 6.260.000 | |
2015-02-10 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
P - Purchase | 1.440.000 | 17.830.305 | 8,79 | 8,75 | 12.600.000 | 156.015.169 | |
2015-01-27 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 55.556 | 5.483.957 | 1,02 | 27,00 | 1.500.012 | 148.066.839 | |
2015-01-27 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 500.000 | 6.246.167 | 8,70 | 27,00 | 13.500.000 | 168.646.509 | |
2015-01-05 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 58.800 | 58.800 | |||||
2015-01-05 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 58.800 | 58.800 | |||||
2015-01-05 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 1.068 | 1.068 | |||||
2015-01-05 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 28.593 | 105.204 | 37,32 | ||||
2015-01-05 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 28.593 | 55.784.792 | 0,05 | ||||
2015-01-05 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 28.593 | 55.783.837 | 0,05 | ||||
2015-01-05 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | 139.811 | 4.851.663 | 2,97 | ||||
2015-01-05 |
|
4 | XON |
INTREXON CORP
Common Stock |
J - Other | -1.679.578 | 0 | -100,00 | ||||
2015-01-05 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
A - Award | 16.707 | 95.648 | 21,16 | ||||
2014-12-10 | 3 | HSGX |
HISTOGENICS CORP
Common Stock |
5.381.140 | ||||||||
2014-12-10 | 3 | HSGX |
HISTOGENICS CORP
Common Stock |
5.381.140 | ||||||||
2014-12-10 | 3 | HSGX |
HISTOGENICS CORP
Common Stock |
5.381.140 | ||||||||
2014-06-06 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
P - Purchase | 400.000 | 9.619.512 | 4,34 | 2,90 | 1.160.000 | 27.896.585 | |
2014-05-29 |
|
4/A | XON |
INTREXON CORP
Common Stock |
P - Purchase | 32.019 | 829.379 | 4,02 | 15,63 | 500.457 | 12.963.194 | |
2014-05-29 |
|
4/A | XON |
INTREXON CORP
Common Stock |
P - Purchase | 18.066 | 797.360 | 2,32 | 15,89 | 287.069 | 12.670.050 | |
2014-05-29 |
|
4/A | XON |
INTREXON CORP
Common Stock |
P - Purchase | 2.160 | 129.794 | 1,69 | 14,24 | 30.758 | 1.848.267 | |
2014-05-29 |
|
4/A | XON |
INTREXON CORP
Common Stock |
P - Purchase | 15.088 | 779.294 | 1,97 | 13,42 | 202.481 | 10.458.125 | |
2014-05-15 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
A - Award | 24.876 | 3.504.876 | 0,71 | ||||
2014-05-13 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 32.019 | 829.379 | 4,02 | 15,63 | 500.457 | 12.963.194 | |
2014-05-13 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 18.066 | 797.360 | 2,32 | 15,89 | 287.069 | 12.670.050 | |
2014-05-13 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 15.088 | 779.294 | 1,97 | 13,42 | 202.481 | 10.458.125 | |
2014-03-31 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 243.001 | 243.001 | 25,72 | 6.249.986 | 6.249.986 | ||
2014-03-07 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Series B Convertible Preferred Stock |
P - Purchase | 288.659 | 288.659 | 4,85 | 1.399.996 | 1.399.996 | ||
2014-03-07 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Series B Convertible Preferred Stock |
P - Purchase | 577.319 | 577.319 | 4,85 | 2.799.997 | 2.799.997 | ||
2014-03-07 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Series B Convertible Preferred Stock |
P - Purchase | 577.319 | 577.319 | 4,85 | 2.799.997 | 2.799.997 | ||
2014-02-18 | 3 | APHB |
AmpliPhi Biosciences Corp
Common Stock |
64.000.000 | ||||||||
2014-02-18 | 3 | APHB |
AmpliPhi Biosciences Corp
Common Stock |
68.000.000 | ||||||||
2014-02-18 | 3 | APHB |
AmpliPhi Biosciences Corp
Common Stock |
64.000.000 | ||||||||
2014-02-18 | 3 | APHB |
AmpliPhi Biosciences Corp
Common Stock |
68.000.000 | ||||||||
2014-02-18 | 3 | APHB |
AmpliPhi Biosciences Corp
Common Stock |
64.000.000 | ||||||||
2014-02-18 | 3 | APHB |
AmpliPhi Biosciences Corp
Common Stock |
68.000.000 | ||||||||
2014-01-28 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
P - Purchase | 1.024.590 | 6.024.915 | 20,49 | 4,88 | 4.999.999 | 29.401.585 | |
2014-01-03 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
A - Award | 18.818 | 78.941 | 31,30 | ||||
2013-12-26 |
|
4 | OGEN |
ORAGENICS INC
Convertible Promissory Note |
C - Conversion | 0 | ||||||
2013-12-26 |
|
4 | OGEN |
ORAGENICS INC
Common Stock |
C - Conversion | 698.241 | 8.838.666 | 8,58 | 2,82 | 1.969.040 | 24.925.038 | |
2013-12-19 |
|
4 | SYN |
Synthetic Biologics, Inc.
Common Stock |
P - Purchase | 2.000.000 | 8.675.768 | 29,96 | 1,00 | 2.000.000 | 8.675.768 | |
2013-12-19 |
|
4 | SYN |
Synthetic Biologics, Inc.
Common Stock |
P - Purchase | 500.000 | 3.625.000 | 16,00 | 1,00 | 500.000 | 3.625.000 | |
2013-11-22 |
|
4 | OGEN |
ORAGENICS INC
Common Stock |
P - Purchase | 1.099.490 | 8.140.425 | 15,62 | 2,50 | 2.748.725 | 20.351.062 | |
2013-11-22 |
|
4 | OGEN |
ORAGENICS INC
Common Stock |
P - Purchase | 143.000 | 1.000.555 | 16,68 | 2,50 | 357.500 | 2.501.388 | |
2013-10-31 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
P - Purchase | 2.857.143 | 16.390.305 | 21,11 | 3,50 | 10.000.000 | 57.366.068 | |
2013-10-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Option to Purchase Common Stock |
X - Other | -10.000 | 0 | -100,00 | ||||
2013-10-16 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
X - Other | 10.000 | 3.480.000 | 0,29 | 4,94 | 49.400 | 17.191.200 | |
2013-10-03 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
P - Purchase | 2.439.024 | 5.000.325 | 95,23 | 4,10 | 9.999.998 | 20.501.332 | |
2013-10-03 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
P - Purchase | 1.219.512 | 9.219.512 | 15,24 | 4,10 | 4.999.999 | 37.799.999 | |
2013-10-02 |
|
4 | OGEN |
ORAGENICS INC
Common Stock |
P - Purchase | 2.648.510 | 7.040.935 | 60,30 | 3,00 | 7.945.530 | 21.122.805 | |
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock |
C - Conversion | -50.904 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock |
C - Conversion | -38.510 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock |
C - Conversion | -33.016 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock |
C - Conversion | -86.200 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock |
C - Conversion | -875.800 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock |
C - Conversion | -452.537 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock |
C - Conversion | -141.588 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock |
C - Conversion | -64.300 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock |
C - Conversion | -394.995 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock |
C - Conversion | -448.185 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock |
C - Conversion | -362.286 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock |
C - Conversion | -77.419 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock |
C - Conversion | -49.980 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock |
C - Conversion | -42.794 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 3.709 | 73.668 | 5,30 | 16,00 | 59.344 | 1.178.688 | |
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 69.959 | 69.959 | |||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 51.213 | 940.426 | 5,76 | 16,00 | 819.408 | 15.046.816 | |
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 889.213 | 889.213 | |||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 38.628 | 764.206 | 5,32 | 16,00 | 618.048 | 12.227.296 | |
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 725.578 | 725.578 | |||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 5.185 | 102.437 | 5,33 | 16,00 | 82.960 | 1.638.992 | |
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 97.252 | 97.252 | |||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock |
C - Conversion | -47.055 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock |
C - Conversion | -40.968 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock |
C - Conversion | -39.492 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock |
C - Conversion | -109.200 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock |
C - Conversion | -1.108.800 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock |
C - Conversion | -128.508 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock |
C - Conversion | -64.300 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock |
C - Conversion | -361.815 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock |
C - Conversion | -422.375 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock |
C - Conversion | -312.890 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock |
C - Conversion | -75.839 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock |
C - Conversion | -49.980 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock |
C - Conversion | -42.794 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 3.747 | 76.611 | 5,14 | 16,00 | 59.952 | 1.225.776 | |
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 72.864 | 72.864 | |||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 49.028 | 818.461 | 6,37 | 16,00 | 784.448 | 13.095.376 | |
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 769.433 | 769.433 | |||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 35.942 | 699.586 | 5,42 | 16,00 | 575.072 | 11.193.376 | |
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 663.644 | 663.644 | |||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 5.133 | 101.482 | 5,33 | 16,00 | 82.128 | 1.623.712 | |
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 96.349 | 96.349 | |||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock |
C - Conversion | -17.555 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock |
C - Conversion | -178.254 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock |
C - Conversion | -19.808 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock |
C - Conversion | -295.858 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series B Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series B Convertible Preferred Stock |
C - Conversion | -694.000 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series B-1 Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series B-1 Convertible Preferred Stock |
C - Conversion | -1.212.360 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock |
C - Conversion | -909.272 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock |
C - Conversion | -1.977.666 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock |
C - Conversion | -295.514 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock |
C - Conversion | -1.917.360 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock |
C - Conversion | -299.532 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock |
C - Conversion | -958.680 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock |
C - Conversion | -149.766 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 7.873 | 131.081 | 6,39 | 16,00 | 125.968 | 2.097.296 | |
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 123.208 | 123.208 | |||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 10.138 | 179.199 | 6,00 | 16,00 | 162.208 | 2.867.184 | |
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 169.061 | 169.061 | |||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 70.646 | 1.679.578 | 4,39 | 16,00 | 1.130.336 | 26.873.248 | |
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 1.608.932 | 1.608.932 | |||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 65.983 | 1.196.077 | 5,84 | 16,00 | 1.055.728 | 19.137.232 | |
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 1.130.094 | 1.130.094 | |||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 9.859 | 178.724 | 5,84 | 16,00 | 157.744 | 2.859.584 | |
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 168.865 | 168.865 | |||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 89.853 | 1.356.648 | 7,09 | 16,00 | 1.437.648 | 21.706.368 | |
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 1.266.795 | 1.266.795 | |||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 44.926 | 678.323 | 7,09 | 16,00 | 718.816 | 10.853.168 | |
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 633.397 | 633.397 | |||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock |
C - Conversion | -1.917.360 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock |
C - Conversion | -299.532 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C-1 Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C-1 Convertible Preferred Stock |
C - Conversion | -15.934.528 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C-2 Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C-2 Convertible Preferred Stock |
C - Conversion | -18.617.020 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C-3 Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C-3 Convertible Preferred Stock |
C - Conversion | -13.271.277 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock |
C - Conversion | -4.437.870 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock |
C - Conversion | -3.047.620 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series C Convertible Preferred Stock |
C - Conversion | -656.716 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series D Convertible Preferred Stock |
C - Conversion | -4.053.784 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock |
C - Conversion | -2.976.756 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock |
C - Conversion | -190.477 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock |
C - Conversion | -4.620.071 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock |
C - Conversion | -3.054.236 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series F Convertible Preferred Stock |
C - Conversion | -3.054.236 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock Dividend |
C - Conversion | 0 | 0 | 16,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Series E Convertible Preferred Stock |
C - Conversion | -5.023.770 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 89.853 | 1.356.648 | 7,09 | 16,00 | 1.437.648 | 21.706.368 | |
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 1.266.795 | 1.266.795 | |||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 1.360.445 | 22.636.052 | 6,39 | 16,00 | 21.767.120 | 362.176.832 | |
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 19.743.741 | 21.275.607 | 1.288,87 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 636.205 | 13.340.645 | 5,01 | 16,00 | 10.179.280 | 213.450.320 | |
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 11.861.008 | 12.704.440 | 1.406,28 | ||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 319.135 | 4.711.852 | 7,27 | 16,00 | 5.106.160 | 75.389.632 | |
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 4.392.717 | 4.392.717 | |||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 12.500 | 127.634 | 10,86 | 16,00 | 200.000 | 2.042.144 | |
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 6.290 | 115.134 | 5,78 | 16,00 | 100.640 | 1.842.144 | |
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 108.844 | 108.844 | |||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 937.500 | 5.428.401 | 20,88 | 16,00 | 15.000.000 | 86.854.416 | |
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
P - Purchase | 937.500 | 5.428.401 | 20,88 | 16,00 | 15.000.000 | 86.854.416 | |
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 105.584 | 4.490.901 | 2,41 | 16,00 | 1.689.344 | 71.854.416 | |
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 4.385.317 | 4.385.317 | |||||
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 192.665 | 4.808.667 | 4,17 | 16,00 | 3.082.640 | 76.938.672 | |
2013-08-15 |
|
4 | XON |
INTREXON CORP
Common Stock |
C - Conversion | 4.616.002 | 4.616.002 | |||||
2013-08-07 | 3 | XON |
INTREXON CORP
Common Stock |
1.531.866 | ||||||||
2013-08-07 | 3 | XON |
INTREXON CORP
Common Stock |
843.432 | ||||||||
2013-07-30 |
|
4 | FCSC |
Fibrocell Science, Inc.
Common Stock |
P - Purchase | 1.243.781 | 2.561.301 | 94,40 | 6,03 | 7.499.999 | 15.444.645 | |
2013-06-26 | 3 | SNGX |
SOLIGENIX, INC.
Common Stock |
3.333.333 | ||||||||
2013-06-26 | 3 | SNGX |
SOLIGENIX, INC.
Common Stock |
1.034.483 | ||||||||
2013-05-20 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
A - Award | 20.000 | 3.470.000 | 0,58 | ||||
2013-01-29 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Warrant to Purchase Common Stock |
P - Purchase | 600.000 | 600.000 | |||||
2013-01-29 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Warrant to Purchase Common Stock |
P - Purchase | 1.200.000 | 1.200.000 | |||||
2013-01-29 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Warrant to Purchase Common Stock |
P - Purchase | 1.200.000 | 1.200.000 | |||||
2013-01-29 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Common Stock |
P - Purchase | 1.200.000 | 1.849.181 | 184,85 | ||||
2013-01-29 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Common Stock |
P - Purchase | 2.400.000 | 3.698.361 | 184,85 | ||||
2013-01-29 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Common Stock |
P - Purchase | 2.400.000 | 3.698.361 | 184,85 | ||||
2013-01-02 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
A - Award | 17.546 | 60.123 | 41,21 | ||||
2012-11-09 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
P - Purchase | 3.636.926 | 13.533.162 | 36,75 | ||||
2012-10-31 |
|
4 | SYN |
Synthetic Biologics, Inc.
Common Stock |
P - Purchase | 3.125.000 | 3.125.000 | 1,60 | 5.000.000 | 5.000.000 | ||
2012-10-19 | 3 | SYN |
Synthetic Biologics, Inc.
Common Stock |
6.675.768 | ||||||||
2012-10-15 | 3 | FCSC |
Fibrocell Science, Inc.
Common Stock |
200.000.000 | ||||||||
2012-10-15 | 3 | FCSC |
Fibrocell Science, Inc.
Common Stock |
32.938.000 | ||||||||
2012-08-02 |
|
4 | ORNI |
ORAGENICS INC
Common Stock |
P - Purchase | 857.555 | 857.555 | 1,50 | 1.286.332 | 1.286.332 | ||
2012-06-12 | 3 | ORNI |
ORAGENICS INC
Common Stock |
4.392.425 | ||||||||
2012-06-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
P - Purchase | 2.731 | 331.394 | 0,83 | 7,48 | 20.428 | 2.478.827 | |
2012-06-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
P - Purchase | 2.732 | 331.395 | 0,83 | 7,48 | 20.435 | 2.478.835 | |
2012-06-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
P - Purchase | 44.823 | 328.663 | 15,79 | 7,37 | 330.346 | 2.422.246 | |
2012-06-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
P - Purchase | 44.823 | 328.663 | 15,79 | 7,37 | 330.346 | 2.422.246 | |
2012-06-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
P - Purchase | 49.540 | 283.840 | 21,14 | 7,39 | 366.101 | 2.097.578 | |
2012-06-05 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
P - Purchase | 49.540 | 283.840 | 21,14 | 7,39 | 366.101 | 2.097.578 | |
2012-05-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
P - Purchase | 299.007 | 3.977.445 | 8,13 | 7,50 | 2.242.552 | 29.830.838 | |
2012-05-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
P - Purchase | 344.910 | 3.678.438 | 10,35 | 7,44 | 2.566.130 | 27.367.579 | |
2012-05-17 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
P - Purchase | 427.581 | 3.333.528 | 14,71 | 7,35 | 3.142.720 | 24.501.431 | |
2012-05-07 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
A - Award | 20.000 | 3.450.000 | 0,58 | ||||
2012-02-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
P - Purchase | 185.000 | 234.300 | 375,25 | 10,61 | 1.962.850 | 2.485.923 | |
2012-02-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
P - Purchase | 185.000 | 234.300 | 375,25 | 10,61 | 1.962.850 | 2.485.923 | |
2012-02-13 |
|
4 | HALO |
HALOZYME THERAPEUTICS INC
Common Stock |
P - Purchase | 990.000 | 2.905.947 | 51,67 | 10,61 | 10.503.900 | 30.832.098 | |
2012-02-07 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Warrant to Purchase Common Stock |
C - Conversion | 300.000 | 300.000 | |||||
2012-02-07 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Warrant to Purchase Common Stock |
C - Conversion | 600.000 | 600.000 | |||||
2012-02-07 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Warrant to Purchase Common Stock |
C - Conversion | 600.000 | 600.000 | |||||
2012-02-07 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Convertible Promissory Note |
C - Conversion | 0 | ||||||
2012-02-07 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Convertible Promissory Note |
C - Conversion | 0 | ||||||
2012-02-07 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Convertible Promissory Note |
C - Conversion | 0 | ||||||
2012-02-07 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Common Stock |
C - Conversion | 600.000 | 649.181 | 1.219,98 | ||||
2012-02-07 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Common Stock |
C - Conversion | 1.200.000 | 1.298.361 | 1.220,00 | ||||
2012-02-07 |
|
4 | TBIO.OB |
TRANSGENOMIC INC
Common Stock |
C - Conversion | 1.200.000 | 1.298.361 | 1.220,00 | ||||
2012-01-23 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
P - Purchase | 1.923.075 | 9.896.236 | 24,12 | 5,20 | 9.999.990 | 51.460.427 | |
2012-01-03 |
|
4 | ZIOP |
ZIOPHARM ONCOLOGY INC
Common Stock |
A - Award | 17.577 | 42.577 | 70,31 |